AMN Healthcare Services (AMN) 10-K 21 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Feb. 18, 2014	Jun. 30, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'AMN HEALTHCARE SERVICES INC	'	'
Entity Central Index Key	'0001142750	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Amendment Flag	'false	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Accelerated Filer	'	'
Entity Common Stock, Shares Outstanding	'	46,359,065	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$557,172,455

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$15,580	$5,681
Accounts receivable, net of allowances of $5,118 and $5,003 at December 31, 2013 and 2012, respectively	147,477	142,510
Accounts receivable, subcontractor	18,271	18,467
Deferred income taxes, net	24,938	18,123
Prepaid and other current assets	23,833	18,963
Total current assets	230,099	203,744
Restricted cash, cash equivalents and investments	23,115	18,861
Fixed assets, net	21,158	14,815
Other assets	23,023	19,732
Goodwill	144,642	123,324
Intangible assets, net	150,197	136,910
Total assets	592,234	517,386
Current liabilities:	'	'
Accounts payable and accrued expenses	69,407	52,619
Accrued compensation and benefits	54,825	49,443
Revolving credit facility	10,000	0
Other current liabilities	6,060	7,463
Total current liabilities	140,292	109,525
Notes payable, net of discount	148,672	158,178
Other long-term liabilities	85,528	67,572
Total liabilities	374,492	335,275
Commitments and contingencies (Note 12)	'	'
Stockholders’ equity:	'	'
Preferred stock, $0.01 par value; 10,000 shares authorized; none issued and outstanding at December 31, 2013 and 2012 (Note 10(a))	0	0
Common stock, $0.01 par value; 200,000 shares authorized; 46,011 and 45,691 shares issued and outstanding at December 31, 2013 and 2012, respectively	460	457
Additional paid-in capital	429,055	424,292
Accumulated deficit	-211,275	-242,195
Accumulated other comprehensive loss	-498	-443
Total stockholders’ equity	217,742	182,111
Total liabilities and stockholders’ equity	$592,234	$517,386

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, except Per Share data, unless otherwise specified
Accounts receivable, allowance	$5,118	$5,003
Preferred stock, par value	$0.01	$0.01
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	200,000	200,000
Common stock, shares issued	46,011	45,691
Common stock, shares outstanding	46,011	45,691

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Loss) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Revenue	$1,011,816	$953,951	$887,466
Cost of revenue	714,536	683,554	638,147
Gross profit	297,280	270,397	249,319
Operating expenses:	'	'	'
Selling, general and administrative	218,233	202,904	195,348
Depreciation and amortization	13,545	14,151	16,324
Total operating expenses	231,778	217,055	211,672
Income from operations	65,502	53,342	37,647
Interest expense, net (including loss on debt extinguishment of $434, $9,815, and $0 for the years ended December 31, 2013, 2012, and 2011, respectively)	9,665	26,019	23,727
Income from continuing operations before income taxes	55,837	27,323	13,920
Income tax expense	22,904	11,010	8,904
Income from continuing operations	32,933	16,313	5,016
Income (loss) from discontinued operations, net of tax	0	823	-31,281
Net income (loss)	32,933	17,136	-26,265
Basic income (loss) per common share from:	'	'	'
Continuing operations (in dollars per share)	$0.72	$0.36	$0.12
Discontinued operations (in dollars per share)	$0	$0.02	($0.78)
Net income (loss) (in dollars per share)	$0.72	$0.38	($0.66)
Diluted income (loss) per common share from:	'	'	'
Continuing operations (in dollars per share)	$0.69	$0.35	$0.11
Discontinued operations (in dollars per share)	$0	$0.02	($0.68)
Net income (loss) (in dollars per share)	$0.69	$0.37	($0.57)
Weighted average common shares outstanding:	'	'	'
Basic (in dollars per share)	45,963	41,632	39,913
Diluted (in dollars per share)	47,787	46,709	45,951
Other comprehensive income (loss) - foreign currency translation	-55	-70	48
Comprehensive income (loss)	$32,878	$17,066	($26,217)

Consolidated_Statements_of_Com1

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Loss on debt extinguishment	$434	$9,815	$0

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit	Accumulated Other Comprehensive Loss
In Thousands, unless otherwise specified
Balance at Dec. 31, 2010	$153,455	$392	$386,550	$0	($233,066)	($421)
Balance, Shares at Dec. 31, 2010	'	39,186	'	0	'	'
Statement of Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Equity awards vested and issued and exercised, shares	'	418	'	'	'	'
Equity awards vested and issued and exercised	-2,058	4	-2,062	'	'	'
Preferred Stock converted to common stock, shares	'	850	'	'	'	'
Preferred Stock converted to common stock	4,300	9	4,291	'	'	'
Income tax shortfall from equity awards vested and issued and exercised	-953	'	-953	'	'	'
Share-based compensation	7,132	'	7,132	'	'	'
Comprehensive income (loss)	-26,217	'	'	'	-26,265	48
Balance at Dec. 31, 2011	135,659	405	394,958	0	-259,331	-373
Balance, Shares at Dec. 31, 2011	'	40,454	'	0	'	'
Statement of Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Equity awards vested and issued and exercised, shares	'	486	'	'	'	'
Equity awards vested and issued and exercised	-545	5	-550	'	'	'
Preferred Stock converted to common stock, shares	'	4,751	'	'	'	'
Preferred Stock converted to common stock	24,039	47	23,992	'	'	'
Preferred Stock retirement	37	'	37	'	'	'
Income tax shortfall from equity awards vested and issued and exercised	-369	'	-369	'	'	'
Share-based compensation	6,224	'	6,224	'	'	'
Comprehensive income (loss)	17,066	'	'	'	17,136	-70
Balance at Dec. 31, 2012	182,111	457	424,292	0	-242,195	-443
Balance, Shares at Dec. 31, 2012	'	45,691	'	0	'	'
Statement of Stockholders' Equity [Roll Forward]	'	'	'	'	'	'
Settlement of acquisition share holdback, shares	'	'	'	0	'	'
Settlement of acquisition share holdback	-3,046	'	'	-3,046	'	'
Treasury stock retirement, shares	'	-204	'	0	'	'
Treasury stock retirement	0	-2	-1,031	3,046	-2,013	'
Equity awards vested and issued and exercised, shares	'	524	'	'	'	'
Equity awards vested and issued and exercised	-1,493	5	-1,498	'	'	'
Income tax benefit from equity awards vested and issued and exercised	1,167	'	1,167	'	'	'
Share-based compensation	6,125	'	6,125	'	'	'
Comprehensive income (loss)	32,878	'	'	'	32,933	-55
Balance at Dec. 31, 2013	$217,742	$460	$429,055	$0	($211,275)	($498)
Balance, Shares at Dec. 31, 2013	'	46,011	'	0	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:	'	'	'
Net income (loss)	$32,933	$17,136	($26,265)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'	'
Depreciation and amortization	13,545	14,151	16,416
Non-cash interest expense	1,336	2,921	3,787
Increase in allowances for doubtful accounts and sales credits	4,628	6,786	4,411
Provision for deferred income taxes	3,031	6,951	-1,795
Share-based compensation	6,125	6,224	7,132
Excess tax benefit from share-based compensation	-1,521	-44	-109
Holdback settlement in equity from prior acquisition	-3,046	0	0
Impairment charges for discontinued operations	0	0	38,898
Gain on sale of discontinued operations	0	-1,187	0
Loss on disposal or sale of fixed assets	14	32	108
Write-off of assets due to discontinued operations	0	0	571
Loss on debt extinguishment	434	9,815	0
Changes in assets and liabilities, net of effects from acquisition and divestiture:	'	'	'
Accounts receivable	-8,644	-2,642	-23,601
Accounts receivable, subcontractor	196	4,030	-5,415
Income taxes receivable	-1,572	3,035	388
Prepaid expenses and other current assets	6,024	-8,684	-825
Other assets	-3,908	-2,920	-247
Accounts payable and accrued expenses	4,337	2,833	3,660
Accrued compensation and benefits	5,242	5,794	6,035
Other liabilities	3,784	-3,719	-3,837
Restricted cash, cash equivalents and investments balance	-4,301	0	0
Net cash provided by operating activities	58,637	60,512	19,312
Cash flows from investing activities:	'	'	'
Purchase and development of fixed assets	-9,047	-5,472	-4,648
Change in restricted cash, cash equivalents and investments balance	47	-617	2,717
Cash payment for holdback liability for prior year acquisitions	0	0	-50
Cash paid for acquisitions	-39,500	0	0
Proceeds from sales of assets held for sale	600	9,050	0
Net cash provided by (used in) investing activities	-47,900	2,961	-1,981
Cash flows from financing activities:	'	'	'
Capital lease repayments	-681	-650	-673
Proceeds from revolving credit facility	26,000	0	19,900
Payments on revolving credit facility	-16,000	-3,000	-16,900
Payment of financing costs	-364	-3,938	-855
Prepayment penalty associated with the prior credit facilities	0	-1,200	0
Payments on term loan credit facility	-10,000	-40,380	0
Proceeds from term loan credit facility, net of discount	0	198,000	0
Repayments of prior notes payable	0	-206,500	-13,875
Proceeds from exercise of equity awards	1,177	530	0
Cash paid for shares withheld for taxes	-2,670	-1,075	-2,058
Excess tax benefit from share-based compensation	1,521	44	109
Change in bank overdraft	234	-3,515	-948
Net cash used in financing activities	-783	-61,684	-15,300
Effect of exchange rate changes on cash	-55	-70	48
Net increase in cash and cash equivalents	9,899	1,719	2,079
Cash and cash equivalents at beginning of year	5,681	3,962	1,883
Cash and cash equivalents at end of year	15,580	5,681	3,962
Supplemental disclosures of cash flow information:	'	'	'
Cash paid for interest (net of $63, $27 and $70 capitalized in 2013, 2012 and 2011, respectively)	7,405	13,698	19,667
Cash paid for income taxes	18,865	1,860	388
Acquisitions:	'	'	'
Fair value of assets acquired in acquisitions	9,899	0	0
Goodwill	21,318	0	411
Intangible assets	19,790	0	0
Liabilities assumed	-11,507	0	-411
Net cash paid for acquisitions	$39,500	$0	$0

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Interest capitalized	$63	$27	$70

Summary_of_Significant_Account

Summary of Significant Accounting Policies (Notes)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	) Summary of Significant Accounting Policies
	(a) General
	AMN Healthcare Services, Inc. was incorporated in Delaware on November 10, 1997. AMN Healthcare Services, Inc. and its subsidiaries (collectively, the “Company”) provide healthcare workforce solutions and staffing services at acute and sub-acute care hospitals and other healthcare facilities throughout the United States.
	(b) Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
	(c) Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairment, accruals for self-insurance and compensation and related benefits, revenue recognition, accounts receivable, contingencies and litigation, valuation and recognition of share-based payments, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.
	(d) Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments.
	(e) Restricted Cash, Cash Equivalents and Investments
	Restricted cash, cash equivalents and investments primarily represent the cash and U.S. Treasury securities on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit. The original maturity terms for the U.S. Treasury securities were between 6-months and 12-months. See Note (4), “Fair Value Measurement” and Note (8), “Notes Payable and Credit Agreement” for additional information.
	(f) Fixed Assets
	The Company records furniture, equipment, leasehold improvements and internal-use software at cost less accumulated amortization and depreciation. The Company records equipment acquired under capital leases at the present value of the future minimum lease payments. The Company capitalizes major additions and improvements, and expenses maintenance and repairs when incurred. The Company calculates depreciation on furniture, equipment and software using the straight-line method based on the estimated useful lives of the related assets (three to seven years). The Company amortizes leasehold improvements and equipment obtained under capital leases over the shorter of the term of the lease or their estimated useful lives. The Company includes amortization of equipment obtained under capital leases with depreciation expense in the accompanying consolidated financial statements.
	The Company capitalizes and records at cost the costs it incurs to develop internal-use software during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. The Company also capitalizes costs of significant upgrades and enhancements that result in additional functionality, whereas it expenses as incurred costs for maintenance and minor upgrades and enhancements. The Company amortizes capitalized costs using the straight-line method over three to seven years once the software is ready for its intended use.
	The Company reviews long-lived assets for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable and has determined that no triggering events have occurred during the period that would require the Company to perform an impairment test. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to the future undiscounted net cash flows that are expected to be generated by the asset group. If such asset group is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. The Company reports assets to be disposed of at the lower of the carrying amount or fair value less costs to sell.
	(g) Goodwill
	The Company records as goodwill the portion of the purchase price that exceeds the fair value of net assets of entities acquired. The Company evaluates goodwill annually for impairment at the reporting unit level and whenever circumstances occur indicating that goodwill may be impaired. The Company may first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary. The performance of the quantitative impairment test involves a two-step process. The first step of the test involves comparing the fair value of the Company’s reporting units with the reporting unit’s carrying amount, including goodwill. The Company generally determines the fair value of its reporting units using a combination of the income approach (using discounted future cash flows) and the market valuation approach. If the carrying amount of the Company’s reporting units exceeds the reporting unit’s fair value, the Company performs the second step of the test to determine the amount of impairment loss. The second step of the test involves comparing the implied fair value of the Company’s reporting unit’s goodwill with the carrying amount of that goodwill. The amount, by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss.
	The Company experienced declines in home healthcare revenue subsequent to the acquisition of NF Investors, Inc., a Delaware corporation (“NFI”), the parent company of Medfinders, due to federal and state reimbursement rate and funding pressures, such that during the third quarter of 2011, the Company lowered its projected near-term growth rate in the home healthcare services segment. The revised growth rate triggered interim impairment testing on the home healthcare services segment, which was also the reporting unit, as of August 31, 2011. The Company completed the valuation during the fourth quarter of 2011. As a result, the Company recognized a pre-tax goodwill impairment charge of $24,498 in 2011. The Company included the charge in loss from discontinued operations on the consolidated statement of comprehensive loss for the year ended December 31, 2011. Subsequent to year end, the Company completed the sale of this segment. See Note (2), “Discontinued Operations” and Note (5), “Goodwill and Identifiable Intangible Assets” for additional information. The Company performed the annual impairment testing at the reporting unit level at October 31, 2011, and determined there was no further impairment of goodwill.
	The Company performed the annual impairment testing at the reporting unit level at October 31, 2012, and determined there was no impairment of goodwill.
	The Company performed the annual impairment test at October 31, 2013 and determined there was no impairment of goodwill. The Company assessed qualitative factors to determine whether it is more likely than not that the fair value of each reporting unit is less than its carrying amount. As a result of the qualitative assessments, the Company determined that it is more likely than not that the fair value of each of its reporting units is greater than its carrying amount and there was no impairment of goodwill. No events or circumstances have occurred subsequent to October 31, 2013 that indicate that impairment may have occurred.
	(h) Intangible Assets
	Intangible assets consist of identifiable intangible assets acquired through acquisitions. Identifiable intangible assets include tradenames and trademarks, customer relationships, non-compete agreements, staffing databases, acquired technology and online courses. The Company amortizes intangible assets, other than tradenames and trademarks with an indefinite life, using the straight-line method over their useful lives. The Company amortizes non-compete covenants using the straight-line method over the lives of the related agreements. The Company reviews for impairment intangible assets with estimable useful lives whenever events or changes in circumstances indicate that the carrying amount may not be recoverable and has determined that no triggering events have occurred during the period that would require the Company to perform an impairment test.
	The Company does not amortize indefinite lived tradenames and trademarks and instead reviews them for impairment annually. The Company may first perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the indefinite-lived intangible asset is not impaired, no quantitative fair value measurement is necessary. If a quantitative fair value measurement calculation is required for the indefinite-lived intangible assets, the Company compares the fair value of the Company’s indefinite-lived intangibles with their carrying amount. If the carrying amount exceeds the fair value, the Company records the excess as an impairment loss.
	The Company experienced declines in home healthcare revenue subsequent to the acquisition of NFI due to federal and state reimbursement rate and funding pressures, such that during the third quarter of 2011, the Company lowered its projected near-term growth rate in the home healthcare services segment. The revised growth rate triggered interim impairment testing on the home healthcare services segment, which was also the reporting unit, as of August 31, 2011. The Company completed the interim valuation during the fourth quarter of 2011. As a result, the Company recognized a pre-tax impairment charge of $6,700 in 2011 related to an indefinite-lived intangible asset shared by the nurse staffing reporting unit and home healthcare services reporting unit. The Company performed its annual impairment testing at October 31, 2011 and recorded an additional impairment charge of $7,700 related to the above indefinite-lived intangible asset. The additional fourth quarter impairment resulted from the incremental loss of revenue related to the home healthcare services segment from the sale of the disposal group in January 2012. See Note (2), “Discontinued Operations” for additional information. The Company included these charges in loss from discontinued operations on the consolidated statement of comprehensive loss for the year ended December 31, 2011.
	The Company performed its annual impairment testing at October 31, 2012 and determined there was no impairment of its indefinite lived tradenames and trademarks.
	The Company performed its annual impairment testing at October 31, 2013 and determined there was no impairment of its indefinite-lived tradenames and trademarks. The Company assessed qualitative factors to determine whether it is more likely than not that the fair value of tradenames and trademarks are less than their carrying amount. As a result of the qualitative assessments, the Company determined that it is more likely than not that the fair values of its tradenames and trademarks are greater than their carrying amounts and there was no impairment of its indefinite-lived tradenames and trademarks. No events or circumstances have occurred subsequent to October 31, 2013 that indicate that impairment may have occurred.
	(i) Insurance Reserves
	The Company maintains an accrual for professional liability self-insured retention limits that is included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets. The expense is included in the selling, general and administrative expenses in the consolidated statement of comprehensive income (loss). The Company determines the adequacy of this undiscounted accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers, management and third-party administrators, as well as by analyzing independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s actual claims data and industry data to assist the Company in determining the adequacy of its reserves each year.
	In November 2012, the Company established a captive insurance subsidiary, which provides coverage, on an occurrence basis, for professional liability within its nurse and allied healthcare staffing segment. Liabilities include provisions for estimated losses incurred but not yet reported (“IBNR”), as well as provisions for known claims. IBNR reserve estimates involve the use of assumptions and are primarily based upon historical loss experience, industry data and other actuarial assumptions. The Company maintains excess insurance coverage for losses above the per occurrence retention.
	The Company maintains an accrual for workers compensation self-insured retention limits, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheets. The Company determines the adequacy of this undiscounted accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers and third party administrators, as well as by analyzing independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s payroll and actual claims data, as well as industry data, to determine the appropriate reserve both for (1) reported claims and (2) IBNR claims for each policy year. The actuarial study for workers compensation provides the Company with the estimated losses for prior policy years and an estimated percentage of payroll compensation to be accrued for the current year. The Company records its accruals based on the amounts provided in the actuarial study, which it believes is the best estimate of its liability.
	(j) Revenue Recognition
	Revenue consists of fees earned from the permanent and temporary placement of clinicians and physicians. Revenue is recognized when earned and realizable. The Company has contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its clinicians along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its managed services programs. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client. The Company includes payables to subcontractors in accounts payable and accrued expenses in the consolidated balance sheets.
	(k) Accounts Receivable
	The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for doubtful accounts for estimated credit losses resulting from collection risk, including the inability of customers to make required payments under contractual agreements. The allowance for doubtful accounts is reported as a reduction of accounts receivable in the consolidated balance sheets. The Company determines the adequacy of this allowance by evaluating historical delinquency and write-off trends, the financial condition and credit risk and history of each customer, historical payment trends as well as current economic conditions and the impact of such conditions on the customers’ liquidity and overall financial condition. The Company also maintains a sales allowance to reserve for potential credits issued to customers. The Company determines the amount of the reserve based on historical credits issued.
	(l) Concentration of Credit Risk
	The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition, and collateral is generally not required. Credit losses have been within management’s expectations. No single client healthcare system exceeded 10% of consolidated revenue for the years ended December 31, 2013, 2012 and 2011. One managed services program client comprised more than 10% of the Company’s nurse and allied healthcare staffing segment revenue for the year ended December 31, 2013. As of December 31, 2013 and 2012, accounts receivable from the Company’s top five clients represented approximately 12% and 14%, respectively, of the net accounts receivable balance, excluding amounts due to subcontractors.
	The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are also financial instruments that are exposed to concentration of credit risk. The Company maintains its cash balances with high-credit quality and federally insured institutions. Cash balances may be invested in a non-federally insured money market account. As of December 31, 2013 and 2012, there were $23,115 and $18,861, respectively, of restricted cash, cash equivalents and investments primarily invested in a non-federally insured U.S. Treasury security account.
	(m) Income Taxes
	The Company records income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period the changes are enacted. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. The Company recognizes the effect of income tax positions only if it is more likely than not that such positions will be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.
	(n) Fair Value of Financial Instruments
	The carrying amounts of cash and cash equivalents, accounts receivable, subcontractor accounts receivable, income tax receivable, restricted cash, cash equivalents and investments, bank overdraft, accounts payable and accrued expenses, accrued compensation and benefits and other current liabilities approximate their respective fair values due to the short-term nature and liquidity of these financial instruments. The carrying amount of notes payable (both current and long-term portions), net of discount, approximates fair value as the instrument’s interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity (significant other observable inputs - level 2). See Note (8), “Notes Payable and Credit Agreement” for additional information. The fair value of the long-term portion of the Company’s self insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.
	(o) Share-Based Compensation
	The Company accounts for its share-based employee compensation plans by expensing the estimated fair value of share-based awards over the requisite employee service period, which is the vesting period. The Company amortizes the fair value of equity awards granted on a straight-line basis over the requisite service periods of the awards. The measurement of share-based compensation expense is based on several criteria including, but not limited to, the valuation model used and associated input factors such as expected term of the award, stock price volatility, dividend rate, risk free interest rate, and award forfeiture rate. The input factors to use in the valuation model are based on subjective future expectations combined with management judgment. The Company uses historical data to estimate pre-vesting equity award forfeitures and records share-based compensation expense only for those awards that are expected to vest. The excess tax benefits recognized in equity related to equity award exercises are reflected as cash inflows from financing activities in the consolidated statements of cash flows. There is a corresponding cash outflow from operating activities for excess tax benefits in the consolidated statements of cash flows.
	(p) Net Income (Loss) per Common Share
	Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”), are considered to be participating securities and the two-class method is used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income is allocated to participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding Preferred Stock were converted into common stock; accordingly, for the two-class method calculation, the net income was allocated between common stock and Preferred Stock on a proportionate basis using a systematic and reasonable basis (based on number of days outstanding) for purpose of calculating the basic net income per share for the year ended December 31, 2012. For the 2011 basic net loss per common share calculation, the two-class method was not applicable due to the overall net loss for the year. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments and common stock issuable upon conversion of the Preferred Stock.
	Share-based awards to purchase 308, 1,902 and 2,253 shares of common stock for the years ended December 31, 2013, 2012 and 2011, respectively, were not included in the calculation of diluted net income per common share because the effect of these instruments was anti-dilutive.
	The following table sets forth the computation of basic and diluted net income (loss) per common share for the years ended December 31, 2013, 2012 and 2011, respectively:
		Years Ended December 31,
		2013		2012			2011
	Income from continuing operations	$	32,933	$	16,313		$	5,016
	Income (loss) from discontinued operations, net of tax	—		823			(31,281		)
	Net income (loss)	$	32,933	$	17,136		$	(26,265	)
	Less: Allocation to participating securities - from continuing operations	—		(1,249		)	—
	Allocation to participating securities - from discontinued operations	—		(65		)	—
	Total allocation to participating securities	—		(1,314		)	—
	Net income (loss) attributable to common stockholders - basic	$	32,933	$	15,822		$	(26,265	)
	Basic income (loss) per common share from:
	Continuing operations	$	0.72	$	0.36		$	0.12
	Discontinued operations	—		0.02			(0.78		)
	Net income (loss)	$	0.72	$	0.38		$	(0.66	)
	Diluted income (loss) per common share from:
	Continuing operations	$	0.69	$	0.35		$	0.11
	Discontinued operations	—		0.02			(0.68		)
Net income (loss)	$	0.69	$	0.37		$	(0.57	)
Weighted average common shares outstanding—basic	45,963		41,632			39,913
Plus dilutive effect of potential common shares	1,824		5,077			6,038
Weighted average common shares outstanding—diluted	47,787		46,709			45,951
(q) Discontinued Operations
The results of operations of a disposal group held for sale or disposed is presented as discontinued operations when the underlying operations and cash flows of the disposal group will be, or have been, eliminated from the Company’s continuing operations and the Company no longer has the ability to influence the operating and/or financial policies of the disposal group. This assessment is made at the time the disposal group is classified as held for sale and for a one-year period after the sale of the disposal group.
See Note (2), “Discontinued Operations,” for further information regarding the Company’s discontinued operations.
(r) Segment Information
Historically, the Company had four reportable segments: nurse and allied healthcare staffing, locum tenens staffing, physician permanent placement services and home healthcare services. During the fourth quarter of 2011, the Company announced the expected divestiture of its home healthcare services segment, which was completed in January 2012. As a result, the home healthcare services segment was classified as disposal group held for sale as of December 31, 2011, and its results of operations have been classified as discontinued operations for the years ended December 31, 2012 and 2011.
The Company’s management relies on internal management reporting processes that provide revenue and segment operating income for making financial decisions and allocating resources. Segment operating income includes income from operations before depreciation, amortization of intangible assets, share-based compensation expense and other unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
The following table provides a reconciliation of revenue and segment operating income by reportable segment to consolidated results and was derived from the segment’s internal financial information as used for corporate management purposes:
	Years Ended December 31,
	2013		2012			2011
Revenue
Nurse and allied healthcare staffing	$	681,979	$	653,829		$	570,677
Locum tenens staffing	287,484		261,431			277,919
Physician permanent placement services	42,353		38,691			38,870
	$	1,011,816	$	953,951		$	887,466
Segment Operating Income
Nurse and allied healthcare staffing	$	82,458	$	75,907		$	62,786
Locum tenens staffing	24,712		21,613			21,689
Physician permanent placement services	8,929		7,868			10,634
	116,099		105,388			95,109
Unallocated corporate overhead	30,927		31,674			34,040
Depreciation and amortization	13,545		14,151			16,324
Share-based compensation	6,125		6,221			7,098
Interest expense, net (including loss on debt extinguishment of $434, $9,815, and $0 for the years ended December 31, 2013, 2012 and 2011, respectively)	9,665		26,019			23,727
Income from continuing operations before income taxes	$	55,837	$	27,323		$	13,920
(s) Recently Adopted Accounting Pronouncements
In July 2012, the Financial Accounting Standards Board issued an accounting standard update intended to simplify how an entity tests indefinite-lived intangible assets other than goodwill for impairment by providing entities with an option to perform a qualitative assessment to determine whether further impairment testing is necessary. This accounting standard update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this guidance effective January 1, 2013 and performed a qualitative assessment on its annual impairment testing date and such adoption did not have a material effect on its consolidated financial statements. See Note (1)(h), “Summary of Significant Accounting Policies - Intangible Assets” for additional information.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2013
Discontinued Operation, Income (Loss) from Discontinued Operation Disclosures [Abstract]	'
Discontinued Operations	'
	Discontinued Operations
	In January 2012, the Company completed the sale of its home healthcare services segment and the related results of operations have been classified as discontinued operations for the years ended December 31, 2012 and 2011.
	The following table represents the revenue and the components of discontinued operations, net of tax:
		2012			2011
	Revenue	$	3,885		$	53,954
	(Loss) before income taxes	$	(547	)	$	(38,484	)
	Income tax benefit	183			7,203
	Loss from discontinued operations	$	(364	)	$	(31,281	)
	Gain on sale of discontinued operations, before income taxes	$	3,825		$	—
	Income tax expense	(2,638		)	—
	Gain on sale of discontinued operations	$	1,187		$	—
	Total income (loss) from discontinued operations	$	823		$	(31,281	)
	For the year ended December 31, 2011, the loss before income taxes was composed of a $24,498 goodwill impairment charge and $14,400 tradename impairment charge and partially offset by income from operations of $414.

Business_Combinations_Notes

Business Combinations (Notes)	12 Months Ended
	Dec. 31, 2013
Business Combinations [Abstract]	'
Business Combinations	'
	Business Combinations
	ShiftWise Acquisition
	On November 20, 2013, the Company completed its acquisition of ShiftWise, a leading national provider of web-based healthcare workforce solutions, including its VMS utilized by hospitals and other healthcare systems. The strategic combination has added a new and more robust technology platform to the Company’s current workforce solutions offerings and will allow the Company to enhance its managed services business and provide a vendor neutral VMS option for interested clients. The acquisition is not considered a material business combination and, accordingly, pro forma information is not provided. The acquisition was funded through cash on-hand and we have not incurred any material acquisition related costs.
	The Company accounted for the acquisition using the acquisition method of accounting and, accordingly, it recorded the tangible and intangible assets acquired and liabilities assumed at their estimated fair values as of the date of the acquisition. The purchase price of the acquisition totaled $39,500, of which $6,000 was deposited in escrow to satisfy any indemnification claims by the Company with respect to, among other customary items, breaches of representations, warranties and covenants by ShiftWise and post-closing purchase price adjustments. As of the date of this Annual Report on Form 10-K, the Company is still finalizing the allocation of the purchase price. The provisional items pending finalization are primarily related to tax related matters upon the completion of ShiftWise’s tax return, which the Company expects to complete during 2014.
	The preliminary allocation of the purchase price consisted of $9,899 of fair value of assets acquired, $11,507 of liabilities assumed (including $2,639 of deferred tax liabilities), $21,318 of goodwill and $19,790 of identified intangible assets. The intangible assets include the fair value of trade names and trademarks, customer relationships, non-compete agreements and acquired technologies. The weighted average useful life of the acquired intangible assets subject to amortization is approximately 8 years. There is no goodwill recognized as part of this acquisition that is deducible for tax purposes.
	The Company recorded $389 in acquisition-related costs for accounting, legal and other costs in connection with the acquisition within selling, general and administrative expenses in its consolidated statement of comprehensive income for 2013.
	The results of operations of ShiftWise from and after the acquisition date, which were not material, have been included in the nurse and allied healthcare staffing segment in the Company’s consolidated financial statements.

Fair_Value_Measurement_Notes

Fair Value Measurement (Notes)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Measurement	'
	Fair Value Measurement
	The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. It also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:
	Level 1—Quoted prices in active markets for identical assets or liabilities.
	Level 2—Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	Financial assets and liabilities
	The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. As of December 31, 2013 and 2012, the Company held certain assets that are required to be measured at fair value on a recurring basis. These included the restricted cash equivalents and investments and the Company’s investments associated with the Company’s deferred compensation plan. The Company’s restricted cash equivalents and investments typically consist of U.S. Treasury securities and money market funds, and the fair value is based on quoted prices in active markets for identical assets. The Company’s investments associated with its deferred compensation plan typically consist of money market funds and mutual funds that are publicly traded and for which market prices are readily available.
	Financial assets measured at fair value on a recurring basis are summarized below:
		Fair Value Measurements as of December 31, 2013
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	17,817	$	17,817	$	—	$	—
	Money market funds	359		359		—		—
	Total financial assets measured at fair value	$	18,176	$	18,176	$	—	$	—
		Fair Value Measurements as of December 31, 2012
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	18,298	$	18,298	$	—	$	—
	Money market funds	42		42		—		—
	Total financial assets measured at fair value	$	18,340	$	18,340	$	—	$	—
	Non-financial assets and liabilities
	The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill and indefinite-lived intangible assets accounted for pursuant to accounting guidance on goodwill and other intangible assets.
	The Company evaluates goodwill at the reporting unit level and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. The Company determines the fair value of its reporting units based on a combination of inputs including the market capitalization of the Company as well as Level 3 inputs such as discounted cash flows which are not observable from the market, directly or indirectly. The Company determined the fair value of its indefinite-lived intangible assets using the income approach (relief-from-royalty method), based on Level 3 inputs.
	The Company performed its annual impairment testing at October 31, 2013 and 2012, and determined there was no impairment of goodwill. No events have occurred subsequent to October 31, 2013 that indicate impairment may have occurred. See Note (5), “Goodwill and Identifiable Intangible Assets” for additional information.
	The Company did not have any significant non-financial assets or liabilities measured at fair value on December 31, 2013 or 2012.

Goodwill_and_Identifiable_Inta

Goodwill and Identifiable Intangible Assets (Notes)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Identifiable Intangible Assets	'
	Goodwill and Identifiable Intangible Assets
	As of December 31, 2013 and 2012, the Company had the following acquired intangible assets:
		As of December 31, 2013									As of December 31, 2012
		Gross			Accumulated			Net			Gross		Accumulated			Net
		Carrying			Amortization			Carrying			Carrying		Amortization			Carrying
		Amount						Amount			Amount					Amount
	Intangible assets subject to amortization:
	Staffing databases	$	5,450		$	(4,444	)	$	1,006		$	5,450	$	(3,839	)	$	1,611
	Customer relationships	72,990			(29,363		)	43,627			64,990		(24,539		)	40,451
	Tradenames and trademarks	16,871			(6,203		)	10,668			16,871		(5,231		)	11,640
	Non-compete agreements	1,666			(1,484		)	182			1,476		(1,468		)	8
	Acquired technology	6,200			(886		)	5,314			800		(800		)	—
	Online courses	59			(59		)	—			59		(59		)	—
		$	103,236		$	(42,439	)	$	60,797		$	89,646	$	(35,936	)	$	53,710
	Intangible assets not subject to amortization:
	Goodwill							$	144,642							$	123,324
	Tradenames and trademarks							89,400								83,200
								$	234,042							$	206,524
	Aggregate amortization expense for intangible assets was $6,503 and $6,665 for the years ended December 31, 2013 and 2012, respectively. Based on the current amount of intangibles subject to amortization, the estimated amortization expense as of December 31, 2013 is as follows:
		Amount
	Year ending December 31, 2014	$	7,618
	Year ending December 31, 2015	7,414
	Year ending December 31, 2016	6,946
	Year ending December 31, 2017	6,729
	Year ending December 31, 2018	6,527
	Thereafter	25,563
		$	60,797
	The following table summarizes the activity related to the carrying value of goodwill by reportable segment:
		Nurse and Allied		Locum Tenens			Physician		Home Healthcare Services		Total
		Healthcare Staffing		Staffing			Permanent
							Placement
							Services
	Balance, January 1, 2011	76,240		14,466			32,317		31,153		154,176
	Impairment charges	—		—			—		(24,498	)	(24,498	)
	Goodwill acquired from NFI acquisition	253		36			12		110		411
	Goodwill in assets held for sale	—		—			—		(6,765	)	(6,765	)
	Balance, December 31,2012	76,493		14,502			32,329		—		123,324
	Balance, January 1, 2013	76,493		14,502			32,329		—		123,324
	Goodwill acquired from ShiftWise acquisition	21,318		—			—		—		21,318
	Balance, December 31, 2013	97,811		14,502			32,329		—		144,642
	Accumulated impairment loss as of December 31, 2012 and 2013	154,444		53,940			6,555		—		214,939

Balance_Sheet_Details_Notes

Balance Sheet Details (Notes)	12 Months Ended
	Dec. 31, 2013
Balance Sheet Related Disclosures [Abstract]	'
Balance Sheet Details	'
	Balance Sheet Details
	The consolidated balance sheets detail is as follows as of December 31, 2013 and 2012:
		As of December 31,
		2013			2012
	Prepaids and other current assets:
	Prepaid expenses	$	8,128		$	7,282
	Restricted cash	8,325			2,540
	Income taxes receivable	3,084			337
	Other current assets	4,296			8,804
	Prepaids and other current assets	$	23,833		$	18,963
	Fixed assets:
	Furniture and equipment	$	16,413		$	15,786
	Software	62,471			60,195
	Leasehold improvements	5,305			5,062
		84,189			81,043
	Accumulated depreciation and amortization	(63,031		)	(66,228		)
	Fixed assets, net	$	21,158		$	14,815
	Accounts payable and accrued expenses:
	Trade and accrued accounts payable	$	29,857		$	26,229
	Accounts payable to agencies	7,431			—
	Subcontractor payable	22,051			18,129
	Professional liability reserve	8,485			6,535
	Other	1,583			1,726
	Accounts payable and accrued expenses	$	69,407		$	52,619
	Accrued compensation and benefits:
	Accrued payroll	$	17,216		$	14,992
	Accrued bonuses	11,359			10,812
	Accrued travel expense	2,203			3,132
	Accrued health insurance reserve	2,022			2,330
	Accrued workers compensation reserve	4,187			4,161
	Deferred compensation	17,731			13,935
	Other	107			81
	Accrued compensation and benefits	$	54,825		$	49,443
	Other current liabilities:
	Facility client deposits	$	2,409		$	2,831
	Bank overdraft	234			—
	Other	3,417			4,632
	Other current liabilities	$	6,060		$	7,463
	Other long-term liabilities:
	Workers compensation reserve	$	9,849		$	10,549
	Professional liability reserve	21,395			18,053
	Deferred rent	6,625			7,785
	Unrecognized tax benefits	27,178			24,593
	Deferred income taxes, net	17,764			5,281
	Other	2,717			1,311
	Other long-term liabilities	$	85,528		$	67,572

Income_Taxes_Notes

Income Taxes (Notes)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income taxes	'
	Income Taxes
	The provision for income taxes from continuing operations for the years ended December 31, 2013, 2012 and 2011 consists of the following:
		Years Ended December 31,
		2013			2012			2011
	Current income taxes:
	Federal	$	17,268		$	3,334		$	8,493
	State	2,605			727			2,246
	Foreign	—			(2		)	(40		)
	Total	19,873			4,059			10,699
	Deferred income taxes:
	Federal	1,693			5,663			(1,500		)
	State	1,338			1,288			(390		)
	Foreign	—			—			95
	Total	3,031			6,951			(1,795		)
	Provision for income taxes from continuing operations	$	22,904		$	11,010		$	8,904
	The Company’s income tax expense differs from the amount that would have resulted from applying the federal statutory rate of 35% to pretax income (loss) from continuing operations because of the effect of the following items during the years ended December 31, 2013, 2012 and 2011:
		Years Ended December 31,
		2013			2012			2011
	Tax expense at federal statutory rate	$	19,543		$	9,563		$	4,871
	State taxes, net of federal benefit	2,302			1,263			1,067
	Unrecognized tax benefit	1,952			742			2,198
	Non-deductible goodwill and intangibles impairment	(19		)	(18		)	(18		)
	Other, net	(874		)	(540		)	786
	Income tax expense from continuing operations	$	22,904		$	11,010		$	8,904
	The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below as of December 31, 2013 and 2012:
		Years Ended December 31,
		2013			2012
	Deferred tax assets:
	Stock compensation	$	11,998		$	11,100
	Deferred revenue	1,003			1,020
	Allowance for doubtful accounts	1,552			1,663
	Deferred compensation	7,116			5,246
	Accrued expenses, net	23,078			18,691
	Deferred rent	3,209			3,532
	Net operating losses	19,841			18,923
	State taxes	446			—
	Other	1,803			1,212
	Total deferred tax assets	$	70,046		$	61,387
	Deferred tax liabilities:
	Intangibles	$	(56,121	)	$	(43,782	)
	Fixed assets, net	(4,289		)	(3,484		)
	Prepaid expenses	(1,259		)	(813		)
	State taxes	—			(466		)
	Total deferred tax liabilities	$	(61,669	)	$	(48,545	)
	Valuation allowance	$	(1,205	)	$	—
	Net deferred tax assets	$	7,172		$	12,842
	In order to fully realize the deferred tax assets, the Company will need to generate future taxable income of approximately $95,000. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. Based upon the level of historical taxable income and projections for future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these deductible differences. The amount of the deferred tax asset considered realizable, however, could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced.
	A portion of the deferred tax assets recorded in 2010 and 2013 is related to net operating losses (“NOL”) from the NFI and ShiftWise acquistions. The amount of NOL has been the subject of an evaluation under the NOL limitation rules of Internal Revenue Code (“IRC”) Section 382 and corresponding state authorities related to NOL tax attributes from acquired companies and the balances reflect those limitations.
	As of December 31, 2013, the Company has $45,308 of federal NOL carryforwards from the NFI and ShiftWise acquisitions, which are set to expire by 2029. As of December 31, 2013, the Company has state net operating loss carryforwards of $50,000 that are set to expire at various dates between 2014 and 2032. Of this amount, $13,500 is related to the ShiftWise acquistion. A full valuation allowance has been established for this state NOL. Further analysis will be done to determine any potential realization of this state NOL in future Company combined state tax returns.
	As of December 31, 2013, the Company did not provide for United States income taxes or foreign withholding taxes on undistributed earnings from certain non-U.S. subsidiaries that were permanently reinvested outside the United States. In the quarter ended December 31, 2011, the Company decided to cease doing business overseas and to discontinue permanently reinvesting outside the United States and has adjusted the income tax provision in the period to reflect the changes. As of December 31, 2013, the Company’s foreign earnings are insignificant.
	A summary of the changes in the amount of unrecognized tax benefits for 2013, 2012 and 2011 is as follows:
		2013			2012			2011
	Beginning balance of unrecognized tax benefits	$	21,415		$	21,221		$	19,291
	Additions based on tax positions related to the current year	809			1,096			1,541
	Additions based on tax positions of prior years	349			—			512
	Reductions for tax positions of prior years	—			—			(123		)
	Reductions due to lapse of applicable statute of limitation	—			(902		)	—
	Ending balance of unrecognized tax benefits	$	22,573		$	21,415		$	21,221
	At December 31, 2013, if recognized, approximately $24,085, net of $3,093 of temporary differences, would affect the effective tax rate (including interest and penalties).
	The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. The Company has approximately $4,605, $3,178 and $2,710 of accrued interest and penalties related to unrecognized tax benefits at December 31, 2013, 2012 and 2011, respectively. The amount of interest and penalties recognized in 2013, 2012 and 2011 were $1,427, $468 and $709, respectively.
	The Company is subject to taxation in the U.S. and various states and foreign jurisdictions. With few exceptions, as of December 31, 2013, the Company is no longer subject to U.S. federal, state, local or foreign examinations by tax authorities for years before 2005. The Internal Revenue Service (“IRS”) completed its tax audit of the Company for the years 2007, 2008, 2009 and 2010. The IRS has issued a Revenue Agent Report (RAR) to the Company related to its completed tax examination. The RAR seeks adjustments to the Company’s taxable income for 2007-2010 and net operating loss carryforwards from 2005-2006. The adjustments to the Company’s taxable income relate to the proposed disallowance of certain per diems paid to our clinicians and locum tenens providers on the Company’s income tax return. Concurrent with the RAR, the Company received an Employment Tax Examination Report (ETER) for 2009 and 2010. The ETER adjustments propose additional Company payroll tax liabilities and penalties related to the treatment of certain non-taxable per diem allowances and travel benefits. The positions in the RAR and ETER are mutually exclusive. The RAR and ETER contain multiple tax positions, some of which are contrary to each other. Thus, the Company is unable to determine any reasonable range of potential claim at this time.
	The Company has filed a Protest Letter for both the RAR and ETER and intends to defend its position. The Company recently held its first meeting with the IRS Appeals office. The Company does not expect resolution of this matter within twelve months and cannot predict with certainty the timing of such resolution. The Company believes its reserve for unrecognized tax benefits and contingent tax issues is adequate. Notwithstanding, the Company could adjust its provision for income taxes and or contingent tax liability based on future developments. The IRS has begun a separate 2011-2012 income and payroll tax audit during November 2013.
	The Company does not foresee material changes to its gross unrecognized tax benefits within the next twelve months.

Notes_Payable_and_Related_Cred

Notes Payable and Related Credit Agreement (Notes)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Notes Payable and Credit Agreements	'
	Notes Payable and Credit Agreement
	On April 5, 2012, the Company entered into a Credit Agreement (the “Credit Agreement”) with several lenders to provide for two credit facilities (the “Credit Facilities”), including (A) a $50,000 secured revolving credit facility (the “Revolver”) that included a $20,000 sublimit for the issuance of letters of credit and a $15,000 sublimit for swingline loans and (B) a $200,000 face value secured term loan credit facility (the “Term Loan”), net of unamortized original issue discount of $2,000. In addition, the Credit Agreement provides that the Company may from time to time obtain an increase in the Revolver or the Term Loan in an aggregate principal amount not to exceed $75,000 (with a $37,500 sublimit for the Revolver) subject to, among other conditions, the arrangement of additional commitments with financial institutions reasonably acceptable to the Company and the administrative agent.
	The Credit Agreement contains various customary affirmative and negative covenants, including restrictions on assumption of additional indebtedness, declaration and payment of dividends, dispositions of assets, consolidation into another entity, capital expenditures in excess of specified amounts and allowable investments. It also contains financial covenants that require the Company (1) not to exceed a certain maximum consolidated leverage ratio and (2) to maintain a minimum consolidated interest coverage ratio.
	In February 2013, the Company entered into the First Amendment to the Credit Agreement (the “First Amendment”) with the lenders under the Credit Facilities, which went into effect on April 9, 2013. Among other things, the First Amendment amended the Credit Agreement as follows:
	• Reduction in the Interest Rate on the Revolver. Under the original Credit Agreement, borrowings under the Revolver bore interest at floating rates based upon either a LIBOR or a base rate option selected by the Company, plus a spread (the “LIBOR Loan Spread”) of 3.75% to 4.25% and a spread (the “Base Rate Loan Spread”) of 2.75% to 3.25%, respectively, in each case, as specifically determined quarterly based upon the Company’s then-existing consolidated leverage ratio (as defined in the Credit Agreement). The First Amendment reduces each of the Revolver LIBOR Loan Spread and the Revolver Base Rate Loan Spread by 150 basis points, to 2.25% to 2.75% and 1.25% to 1.75%, respectively.
	• Reduction in the Interest Rate on the Term Loan. Under the original Credit Agreement, borrowings under the Term Loan bore interest at floating rates based upon either a LIBOR (with a floor of 1.25%) or a base rate option selected by the Company, plus a LIBOR Loan Spread of 4.50% to 4.75% and a Base Rate Loan Spread of 3.50% to 3.75%, respectively, in each case, as specifically determined quarterly based upon the Company’s then-existing consolidated leverage ratio. The First Amendment reduces each of the Term Loan LIBOR Loan Spread and the Term Loan Base Rate Loan Spread by 150 to 175 basis points (depending on the original Credit Agreement Consolidated Leverage Ratio step) to 3.00% and 2.00%, respectively. It also reduces the LIBOR floor by 50 basis points, from 1.25% to 0.75%.
	• Increased Sublimit for the Issuance of Letter of Credit. The original Credit Agreement provided for a $20,000 sublimit for the issuance of letters of credit under the Revolver. The First Amendment increases the sublimit to $30,000.
	The proceeds from the initial drawdown under the Credit Facilities were used to repay in full all outstanding indebtedness under two prior credit agreements to which the Company was a party and to pay related transaction costs. The Revolver is available for working capital, capital expenditures, permitted acquisitions and general corporate purposes of the Company. The maturity dates of the Revolver and the Term Loan are April 5, 2017 and April 5, 2018, respectively. At December 31, 2013, there was $30,485 of available credit under the Revolver. At December 31, 2013, the Company had $148,672, net of discount, outstanding under the Term Loan at a 3.75% interest rate.
	During the year ended December 31, 2013, the Company made voluntary prepayments on the Term Loan totaling $10,000. The voluntary prepayments the Company has made to date have satisfied all scheduled quarterly principal amortization payments due under the Credit Facilities through the term of the Credit Agreement.
	Credit Agreement balances as of December 31, 2013 and 2012 consisted of the following:
		As of December 31,
		2013			2012
	$50,000 Revolver Facility expiring April 5, 2017 with variable interest rates	$	10,000		$	—
	$200,000 Term Loan due April 5, 2018 with variable interest rates. The weighted average interest rates were 3.17% and 5.97% at December 31, 2013 and 2012, respectively	149,620			159,620
	Total credit agreement debt	159,620			159,620
	Less unamortized discount on the Term Loan	(948		)	(1,442		)
	Less current portion of notes payable, including Revolver	(10,000		)	—
	Long-term portion of notes payable	$	148,672		$	158,178
	Annual principal maturities of outstanding debts, excluding the Revolver, are as follows:
	2014	$	—
	2015	—
	2016	—
	2017	—
	2018	149,620
		$	149,620
	The Company’s outstanding debt instruments at December 31, 2013 and 2012 were secured by substantially all of the assets of the Company and the common stock or equity interests of its domestic subsidiaries.
	Letters of Credit
	At December 31, 2013, the Company maintained outstanding standby letters of credit totaling $27,691 as collateral in relation to its professional liability insurance agreements, workers compensation insurance agreements, and a corporate headquarters office lease agreement. Of the $27,691 outstanding letters of credit, the Company has cash collateralized $18,176 and the remaining amount has been collateralized by the Revolver. Outstanding standby letters of credit at December 31, 2012 totaled $31,879.

Retirement_Plans_Notes

Retirement Plans (Notes)	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Retirement Plans	'
	Retirement Plans
	The Company maintains the AMN Services 401(k) Retirement Savings Plan (the “AMN Plan”), which the Company believes complies with the Internal Revenue Code Section 401(k) provisions. The AMN Plan covers all employees that meet certain age and other eligibility requirements. An annual discretionary matching contribution is determined by the Compensation and Stock Plan Committee of the Board of Directors each year. The amount of the employer contributions, net of forfeitures, under the AMN Plan were $165, $0 and $0 for the years ended December 31, 2013, 2012 and 2011, respectively.
	The Company has a deferred compensation plan for certain executives and key employees (the “Plan”). The Plan is not intended to be tax qualified and is an unfunded plan. The Plan is composed of deferred compensation and all related income and losses attributable thereto. Discretionary matching contributions to the Plan are made that vest incrementally so that the employee is fully vested in the match following five years of employment with the Company. Under the Plan, participants can defer up to 80% of their base salary, 90% of their bonus (100% of their bonus prior to 2011) and 100% of their vested restricted stock units or vested performance restricted stock units. An annual discretionary matching contribution is determined by the Compensation and Stock Plan Committee of the Board of Directors each year. The amount of the employer contributions under the Plan were $384, $343 and $327 for the years ended December 31, 2013, 2012 and 2011, respectively.

Capital_Stock_Notes

Capital Stock (Notes)	12 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Capital Stock	'
	Capital Stock
	(a) Preferred Stock
	The Company has 10,000 shares of preferred stock authorized for issuance in one or more series (including preferred stock designated as Series A Conditional Convertible Preferred Stock), at a par value of $0.01 per share. At December 31, 2013 and 2012, no shares of preferred stock were outstanding.
	(b) Treasury Stock
	In connection with the 2010 acquisition of NFI, 457 shares of the Company’s common stock remained in escrow as of December 31, 2012 for potential Company indemnification claims. During the second quarter of 2013, the Company and former NFI selling shareholders agreed to release all 457 shares in escrow as follows: 1) 204 shares were returned to the Company for settlement of certain indemnification claims, which have been recorded as a $3,046 benefit offsetting selling, general and administrative expenses for the year ended December 31, 2013; and 2) the remaining 253 shares were released from escrow to the former NFI selling shareholders. During 2013, the Company cancelled and retired all 204 shares of treasury stock. Upon cancellation and retirement, these shares were returned to the status of authorized and unissued.

ShareBased_Compensation_Notes

Share-Based Compensation (Notes)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation [Abstract]	'
Share-Based Compensation	'
	Share-Based Compensation
	(a) Equity Award Plans
	Stock Option Plan
	The Company established a stock option plan (the “Stock Option Plan”) to provide a means to attract and retain employees. 4,178 options were authorized for issuance to be granted under the Stock Option Plan. Unless otherwise provided at the time of the grant, the options vest and become exercisable in increments of 25% on each of the first four anniversaries of the date of grant. Options granted under the Stock Option Plan expire on the tenth anniversary of the grant date. On April 12, 2006, 371 shares of common stock reserved for future issuance under The Stock Option Plan were rolled into the Equity Plan, which is discussed below. There will be no further equity awards granted from the Stock Option Plan.
	Equity Plan
	The Company established the AMN Healthcare Equity Plan (as amended or amended and restated from time to time, the “Equity Plan”), which has been approved by the Company’s stockholders. At the time of the Equity Plan’s adoption in 2006, equity awards, based on the Company’s common stock, could be issued for a maximum of 723 shares plus the number of shares of common stock underlying any grants under the Company’s Stock Option Plan that are forfeited, canceled or terminated (other than by exercise) from and after the effective date of the Equity Plan. Pursuant to the Equity Plan, stock options and stock appreciation rights (“SARs”) granted have a maximum contractual life of ten years and exercise prices will be determined at the time of grant and will be no less than fair market value of the underlying common stock on the date of grant. The SARs typically vest ratably over a three-year period, with one third of the awards vesting annually. Any shares to be issued under the Equity Plan will be issued by the Company from authorized but unissued common stock or shares of common stock reacquired by the Company. On April 18, 2007 and April 9, 2009, the Company amended the Equity Plan, with stockholder approval, to increase the number of shares authorized under the Equity Plan by 3,000 and 1,850, respectively. On April 18, 2012, the Company amended and restated the Equity Plan, with stockholder approval to, among other things, increase the number of shares of common stock available for issuance under the Equity Plan by 2,400 shares. At December 31, 2013 and 2012, respectively, 2,173 and 1,904 shares of common stock were reserved for future grants under the Equity Plan.
	Other Plans
	From time to time, we grant, and have granted, key employees inducement awards outside of the Equity Plan (collectively, “Other Plans”), which have consisted of SARs or options, and restricted stock units (“RSUs”), which generally have three-year cliff vesting with a potential for accelerated vesting based on the Company’s achievement of selected targeted financial performance. Although these awards are not made under the Equity Plan, the key terms and conditions of the grant are typically the same as equity awards made under the Equity Plan.
	(b) Share-Based Compensation
	Stock Options and SARs
	Stock options entitle the holder to purchase, at the end of a vesting period, a specified number of shares of the Company’s common stock at a price per share set at the date of grant. SARs entitle the holder to receive, at the end of a vesting period, shares of the Company’s common stock equal in value to the difference between the exercise price of the SAR, which is set at the date of grant, and the fair market value of the Company’s common stock on the date of exercise.
	A summary of stock option and SAR activity under the Stock Option Plan and the Equity Plan and Other Plans are as follows:
		Stock Option Plan							Equity Plan and Other Plans
		Number			Weighted-				Number			Weighted-
		Outstanding			Average				Outstanding			Average
					Exercise Price							Exercise Price
					per Share							per Share
	Outstanding at December 31, 2010	826			$	13.93			1,840			$	9.6
	Granted	—			$	—			—			$	—
	Exercised	—			$	—			(83	)		$	6.31
	Canceled/forfeited/expired	(45	)		$	11.54			(257	)		$	7.77
	Outstanding at December 31, 2011	781			$	14.06			1,500			$	10.1
	Granted	—			$	—			—			$	—
	Exercised	(55	)		$	9.68			(143	)		$	8.1
	Canceled/forfeited/expired	(28	)		$	15.63			(116	)		$	7.55
	Outstanding at December 31, 2012	698			$	14.34			1,241			$	10.57
	Granted	—			$	—			—			$	—
	Exercised	(109	)		$	11.23			(132	)		$	8.31
	Canceled/forfeited/expired	—			$	—			(13	)		$	15.19
	Outstanding at December 31, 2013	589			$	14.92			1,096			$	10.78
	Vested and expected to vest at December 31, 2013	589			$	14.92			1,096			$	10.78
	Exercisable at December 31, 2013	589			$	14.92			1,096			$	10.78
	The following table summarizes stock options and SARs outstanding and exercisable as of December 31, 2013:
				Outstanding									Exercisable
		Range		Number			Weighted-		Weighted-				Number	Weighted-	Weighted-
		Of		Outstanding			Average		Average				Outstanding	Average	Average
		Exercise					Remaining		Exercise Price					Remaining	Exercise Price
		Price					Contractual		per Share					Contractual	per Share
		per Share					Life (Years)							Life (Years)
	Stock Option Plan	$14.86		332			1.34		$	14.86			332	1.34	$	14.86
		$14.94 - $15.47		257			0.54		15				257	0.54	15
				589									589
	Equity Plan and Other Plans	$4.55 - $8.21		128			6.24		$	5.08			128	6.24	$	5.08
		$8.71 - $14.86		667			5.67		8.75				667	5.67	8.75
		$14.94 - $24.47		272			3.61		16.98				272	3.61	16.98
		$24.95		29			3.3		24.95				29	3.3	24.95
				1,096									1,096
	TOTAL			1,685			3.7		$	12.23			1,685	3.7	$	12.23
	There were no SARs granted in 2013, 2012 and 2011. As of December 31, 2013, all stock options and SARs were fully vested. The total intrinsic value of stock options and SARs exercised was $980, $453 and $183 for 2013, 2012 and 2011, respectively. At December 31, 2013 and 2012, the total intrinsic value of stock options and SARs outstanding and exercisable was $5,146 and $3,139, respectively.
	Restricted Stock Units
	RSUs granted under the Equity Plan, generally entitle the holder to receive, at the end of a vesting period, a specified number of shares of the Company’s common stock. The RSUs typically vest at the end of a three-year vesting period, however, 33% of the awards may vest on the 13th month anniversary of the grant date, and 34% on the second anniversary of the grant date, if certain performance targets are met. Share-based compensation cost of RSUs is measured by the market value of the Company’s common stock on the date of grant. The Company also has granted performance restricted stock units (“PRSUs”)under the Equity Plan, including PRSUs that contain a market condition with the ultimate realizable number of PRSUs dependent on relative and absolute total shareholder return over a three-year period, up to a maximum amount to be issued under the award of 175% of the original grant (“TSR PRSUs”). The fair values of TSR PRSUs are estimated using the Monte-Carlo simulation valuation model. During 2013, the Company also granted 291 PRSUs that contain a performance condition, with the ultimate realizable number of PRSUs dependent on the adjusted EBITDA margin performance of the Company for fiscal year 2015, with a range of 0% to 175% of the target amount granted to be issued under the award. Share-based compensation cost of this type of PRSU is measured by the market value of the Company’s common stock on the date of grant, and will be adjusted for estimated achievement of the performance conditions.
	The following table summarizes RSU and PRSU activity for non-vested awards for the years ended December 31, 2013, 2012 and 2011:
		Number of Shares			Weighted Average
					Grant Date
					Fair Value per
					Share
	Unvested at January 1, 2011	1,720			$	9.21
	Granted—RSUs	414			$	6.59
	Granted—PRSUs	288			$	8.53
	Vested	(725	)		$	10.77
	Canceled/forfeited/expired	(168	)		$	8.23
	Unvested at December 31, 2011	1,529			$	7.74
	Granted—RSUs	459			$	6.7
Granted—PRSUs	465			$	8.15
Vested	(716	)		$	7.95
Canceled/forfeited/expired	(78	)		$	6.66
Unvested at December 31, 2012	1,659			$	7.53
Granted—RSUs	285			$	12.86
Granted—PRSUs	291			$	13.86
Vested	(588	)		$	7.02
Canceled/forfeited/expired	(10	)		$	13.06
Unvested at December 31, 2013	1,637			$	9.73
As of December 31, 2013, there was $6,631 of pre-tax total unrecognized compensation cost related to non-vested RSUs and PRSUs, which will be adjusted for future changes in forfeitures. The Company expects to recognize such cost over a period of 1.8 years. As of December 31, 2013 and 2012, the aggregate intrinsic value of the RSUs and PRSUs outstanding was $24,070 and $19,160, respectively.
Share-Based Compensation
The Company amortizes the fair value of equity awards granted on a straight-line basis over the requisite service periods of the awards. The following table shows the total share-based compensation expense, related to all of the Company’s equity awards, recognized for the years ended December 31, 2013, 2012 and 2011:
	Years Ended December 31,
	2013				2012				2011
Share-based employee compensation, before tax	$	6,125			$	6,224			$	7,132
Related income tax benefits	(2,383		)		(2,403		)		(2,746		)
Share-based employee compensation, net of tax	$	3,742			$	3,821			$	4,386

Commitments_and_Contingencies_

Commitments and Contingencies (Notes)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	(a) Legal
	The Company is subject to various claims and legal actions in the ordinary course of its business. Some of these matters relate to professional liability, tax, payroll, contract and employee-related matters and include individual and collective lawsuits, as well as inquiries and investigations by governmental agencies regarding the Company’s employment practices. The most significant matter of which the Company was a defendant was a class action related to wage and hour claims. In the second quarter of 2013, the Company reached a settlement with the plaintiffs in such action (and a related action) for an immaterial amount. The Court granted final approval of the settlement in February 2014. At December 31, 2013, the Company had fully reserved for the settlement of such action, which was included in accounts payable and accrued expenses in the consolidated balance sheet at December 31, 2013.
	Additionally, some of the Company’s clients may also become subject to claims, governmental inquiries and investigations and legal actions relating to services provided by the Company’s clinicians and physicians. From time to time, and depending upon the particular facts and circumstances, the Company may be subject to indemnification obligations under its contracts with such clients relating to these matters.
	Staff Care, Inc., an indirect wholly owned subsidiary of the Company, was the subject of an assessment by the California Employment Development Department (“EDD”) with respect to the payment of certain payroll-related taxes, in connection with locum tenens and allied providers, for the period between April 1, 2001 and June 30, 2007. The Company appealed the EDD’s assessment, but on September 5, 2008, made a payment to the EDD in the amount of $2,295 to cease the accrual of interest while the appeal was pending. On March 28, 2012, Staff Care, Inc. and the EDD entered into a settlement agreement, which resolved all assessments and claims regarding the subject matter of the appeal from April 1, 2001 through June 30, 2007. In connection with the settlement, the EDD refunded to Staff Care $2,012 of the $2,295 payment made by the Company on September 5, 2008. As a result, the Company recorded a $2,012 benefit offsetting selling, general and administrative expenses for the year ended December 31, 2012.
	(b) Leases
	The Company leases certain office facilities and equipment under various operating and capital leases over the future years. The Company recognizes rent expense on a straight-line basis over the lease term. Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) and future minimum capital lease payments as of December 31, 2013 are as follows:
		Capital		Operating
		Leases		Leases (1)
	Years ending December 31,
	2014	$	542	$	14,534
	2015	2		13,679
	2016	—		11,311
	2017	—		10,869
	2018	—		6,194
	Thereafter	—		—
	Total minimum lease payments	$	544	$	56,587
	Less amount representing interest (at rates ranging from 2.8% to 4.6%)	11
	Present value of minimum lease payments	533
	Less current installments of obligations under capital leases	533
	Obligations under capital leases, excluding current installments	$	—
	-1	Total future minimum lease payments have not been reduced by minimum sublease rents of $163 expected to be recovered under the operating subleases.
	Obligations under capital leases are included in other current and other long-term liabilities in the accompanying consolidated balance sheets. Rent expense under operating leases for continuing operations was $14,205, $15,187, and $15,554 for the years ended December 31, 2013, 2012 and 2011, respectively.

Quarterly_Financial_Data_Unaud

Quarterly Financial Data (Unaudited) (Notes)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Quarterly Financial Information	'
	Quarterly Financial Data (Unaudited)
		Year Ended December 31, 2013
		First		Second			Third		Fourth		Total Year
		Quarter		Quarter			Quarter		Quarter
		(In thousands, except per share data)
	Revenue	$	252,120	$	253,943		$	257,095	$	248,658	$	1,011,816
	Gross profit	$	73,007	$	74,413		$	75,667	$	74,193	$	297,280
	Net income	$	7,563	$	8,399		$	8,615	$	8,356	$	32,933
	Net income per share from:
	Basic	$	0.17	$	0.18		$	0.19	$	0.18	$	0.72
	Diluted	$	0.16	$	0.18		$	0.18	$	0.17	$	0.69
		Year Ended December 31, 2012
		First		Second			Third		Fourth		Total Year
		Quarter		Quarter			Quarter		Quarter
		(In thousands, except per share data)
	Revenue	$	226,412	$	235,786		$	243,912	$	247,841	$	953,951
	Gross profit	$	63,214	$	66,973		$	69,583	$	70,627	$	270,397
	Income from continuing operations, net of tax	$	3,453	$	(81	)	$	5,858	$	7,083	$	16,313
	Income (loss) from discontinued operations, net of tax	$	823	$	—		$	—	$	—	$	823
	Net income (loss)	$	4,276	$	(81	)	$	5,858	$	7,083	$	17,136
	Basic income (loss) per share from:
	Continuing operations	$	0.07	$	—		$	0.13	$	0.16	$	0.36
	Discontinued operations	$	0.02	$	—		$	—	$	—	$	0.02
	Net income (loss)	$	0.09	$	—		$	0.13	$	0.16	$	0.38
	Diluted income (loss) per share from:
	Continuing operations	$	0.07	$	—		$	0.12	$	0.15	$	0.35
	Discontinued operations	$	0.02	$	—		$	—	$	—	$	0.02
	Net income (loss)	$	0.09	$	—		$	0.12	$	0.15	$	0.37

Schedule_II_Notes

Schedule II (Notes)	12 Months Ended
	Dec. 31, 2013
Valuation and Qualifying Accounts [Abstract]	'
Valuation and Qualifying Accounts	'
	VALUATION AND QUALIFYING ACCOUNTS
	For Years Ended December 31, 2013, 2012 and 2011
	(in thousands)
	Allowances for Doubtful Accounts and		Balance at		Additions				Deduction (C)			Balance at
	Sales Credits		the Beginning of									End of
			Year		Expenses		Revenue					Year
					and Other		Reductions (B)
					Costs (A)
	Year ended December 31, 2013		$	5,003	$	1,901	$	2,727	$	(4,513	)	$	5,118
	Year ended December 31, 2012		$	4,761	$	2,353	$	4,433	$	(6,544	)	$	5,003
	Year ended December 31, 2011		$	5,597	$	2,776	$	1,635	$	(5,247	)	$	4,761
	(A)	Includes increases in allowance for doubtful accounts.
	(B)	Includes increases in sales allowance for potential credits issued to customers.
	(C)	Includes actual write-offs of uncollectible accounts receivable and credits issued for sales adjustments.
	See accompanying report of independent registered public accounting firm.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	The accompanying consolidated financial statements include the accounts of AMN Healthcare Services, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	'
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to asset impairment, accruals for self-insurance and compensation and related benefits, revenue recognition, accounts receivable, contingencies and litigation, valuation and recognition of share-based payments, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.
Cash and Cash Equivalents	'
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Cash and cash equivalents include currency on hand, deposits with financial institutions and highly liquid investments.
Restricted Cash, Cash Equivalents and Investments	'
	Restricted cash, cash equivalents and investments primarily represent the cash and U.S. Treasury securities on deposit with financial institutions that serve as collateral for the Company’s outstanding letters of credit. The original maturity terms for the U.S. Treasury securities were between 6-months and 12-months. S
Fixed Assets	'
	The Company records furniture, equipment, leasehold improvements and internal-use software at cost less accumulated amortization and depreciation. The Company records equipment acquired under capital leases at the present value of the future minimum lease payments. The Company capitalizes major additions and improvements, and expenses maintenance and repairs when incurred. The Company calculates depreciation on furniture, equipment and software using the straight-line method based on the estimated useful lives of the related assets (three to seven years). The Company amortizes leasehold improvements and equipment obtained under capital leases over the shorter of the term of the lease or their estimated useful lives. The Company includes amortization of equipment obtained under capital leases with depreciation expense in the accompanying consolidated financial statements.
	The Company capitalizes and records at cost the costs it incurs to develop internal-use software during the application development stage. Application development stage costs generally include costs associated with internal-use software configuration, coding, installation and testing. The Company also capitalizes costs of significant upgrades and enhancements that result in additional functionality, whereas it expenses as incurred costs for maintenance and minor upgrades and enhancements. The Company amortizes capitalized costs using the straight-line method over three to seven years once the software is ready for its intended use.
	The Company reviews long-lived assets for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable and has determined that no triggering events have occurred during the period that would require the Company to perform an impairment test. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to the future undiscounted net cash flows that are expected to be generated by the asset group. If such asset group is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. The Company reports assets to be disposed of at the lower of the carrying amount or fair value less costs to sell.
Goodwill	'
	The Company records as goodwill the portion of the purchase price that exceeds the fair value of net assets of entities acquired. The Company evaluates goodwill annually for impairment at the reporting unit level and whenever circumstances occur indicating that goodwill may be impaired. The Company may first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the fair value of the reporting unit is greater than its carrying amount, the quantitative impairment test is unnecessary. The performance of the quantitative impairment test involves a two-step process. The first step of the test involves comparing the fair value of the Company’s reporting units with the reporting unit’s carrying amount, including goodwill. The Company generally determines the fair value of its reporting units using a combination of the income approach (using discounted future cash flows) and the market valuation approach. If the carrying amount of the Company’s reporting units exceeds the reporting unit’s fair value, the Company performs the second step of the test to determine the amount of impairment loss. The second step of the test involves comparing the implied fair value of the Company’s reporting unit’s goodwill with the carrying amount of that goodwill.
Intangible Assets	'
	Intangible assets consist of identifiable intangible assets acquired through acquisitions. Identifiable intangible assets include tradenames and trademarks, customer relationships, non-compete agreements, staffing databases, acquired technology and online courses. The Company amortizes intangible assets, other than tradenames and trademarks with an indefinite life, using the straight-line method over their useful lives. The Company amortizes non-compete covenants using the straight-line method over the lives of the related agreements. The Company reviews for impairment intangible assets with estimable useful lives whenever events or changes in circumstances indicate that the carrying amount may not be recoverable and has determined that no triggering events have occurred during the period that would require the Company to perform an impairment test.
	The Company does not amortize indefinite lived tradenames and trademarks and instead reviews them for impairment annually. The Company may first perform a qualitative assessment to determine whether it is more likely than not that an indefinite-lived intangible asset is impaired. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the indefinite-lived intangible asset is not impaired, no quantitative fair value measurement is necessary. If a quantitative fair value measurement calculation is required for the indefinite-lived intangible assets, the Company compares the fair value of the Company’s indefinite-lived intangibles with their carrying amount. If the carrying amount exceeds the fair value, the Company records the excess as an impairment loss.
Insurance Reserves	'
	The Company maintains an accrual for professional liability self-insured retention limits that is included in accounts payable and accrued expenses and other long-term liabilities in the consolidated balance sheets. The expense is included in the selling, general and administrative expenses in the consolidated statement of comprehensive income (loss). The Company determines the adequacy of this undiscounted accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers, management and third-party administrators, as well as by analyzing independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s actual claims data and industry data to assist the Company in determining the adequacy of its reserves each year.
	In November 2012, the Company established a captive insurance subsidiary, which provides coverage, on an occurrence basis, for professional liability within its nurse and allied healthcare staffing segment. Liabilities include provisions for estimated losses incurred but not yet reported (“IBNR”), as well as provisions for known claims. IBNR reserve estimates involve the use of assumptions and are primarily based upon historical loss experience, industry data and other actuarial assumptions. The Company maintains excess insurance coverage for losses above the per occurrence retention.
	The Company maintains an accrual for workers compensation self-insured retention limits, which is included in accrued compensation and benefits and other long-term liabilities in the consolidated balance sheets. The Company determines the adequacy of this undiscounted accrual by evaluating its historical experience and trends, loss reserves established by the Company’s insurance carriers and third party administrators, as well as by analyzing independent actuarial studies. The Company obtains actuarial studies on a semi-annual basis that use the Company’s payroll and actual claims data, as well as industry data, to determine the appropriate reserve both for (1) reported claims and (2) IBNR claims for each policy year. The actuarial study for workers compensation provides the Company with the estimated losses for prior policy years and an estimated percentage of payroll compensation to be accrued for the current year. The Company records its accruals based on the amounts provided in the actuarial study, which it believes is the best estimate of its liability.
Revenue Recognition	'
	Revenue consists of fees earned from the permanent and temporary placement of clinicians and physicians. Revenue is recognized when earned and realizable. The Company has contracts with healthcare organizations to provide managed services programs. Under these contract arrangements, the Company uses its clinicians along with those of third party subcontractors to fulfill client orders. If the Company uses subcontractors, it records revenue net of related subcontractors expense. The resulting net revenue represents the administrative fee the Company charges for its managed services programs. The Company records subcontractor accounts receivable from the client in the consolidated balance sheets. The Company generally pays the subcontractor after it has received payment from the client.
Accounts Receivable	'
	The Company records accounts receivable at the invoiced amount. Accounts receivable are non-interest bearing. The Company maintains an allowance for doubtful accounts for estimated credit losses resulting from collection risk, including the inability of customers to make required payments under contractual agreements. The allowance for doubtful accounts is reported as a reduction of accounts receivable in the consolidated balance sheets. The Company determines the adequacy of this allowance by evaluating historical delinquency and write-off trends, the financial condition and credit risk and history of each customer, historical payment trends as well as current economic conditions and the impact of such conditions on the customers’ liquidity and overall financial condition. The Company also maintains a sales allowance to reserve for potential credits issued to customers. The Company determines the amount of the reserve based on historical credits issued.
Concentration of Credit Risk	'
	The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition, and collateral is generally not required. Credit losses have been within management’s expectations.
	The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are also financial instruments that are exposed to concentration of credit risk. The Company maintains its cash balances with high-credit quality and federally insured institutions. Cash balances may be invested in a non-federally insured money market account.
Income Taxes	'
	The Company records income taxes using the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period the changes are enacted. In assessing the realizability of deferred tax assets, the Company considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers the scheduled reversal of deferred tax liabilities (including the impact of available carryback and carryforward periods), projected future taxable income, and tax-planning strategies in making this assessment. The Company recognizes the effect of income tax positions only if it is more likely than not that such positions will be sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties related to unrecognized tax benefits in income tax expense.
Fair Value of Financial Instruments	'
	The carrying amounts of cash and cash equivalents, accounts receivable, subcontractor accounts receivable, income tax receivable, restricted cash, cash equivalents and investments, bank overdraft, accounts payable and accrued expenses, accrued compensation and benefits and other current liabilities approximate their respective fair values due to the short-term nature and liquidity of these financial instruments. The carrying amount of notes payable (both current and long-term portions), net of discount, approximates fair value as the instrument’s interest rates are variable and comparable to rates currently offered for similar debt instruments of comparable maturity (significant other observable inputs - level 2). See Note (8), “Notes Payable and Credit Agreement” for additional information. The fair value of the long-term portion of the Company’s self insurance accruals cannot be estimated as the Company cannot reasonably determine the timing of future payments.
Share-Based Compensation	'
	The Company accounts for its share-based employee compensation plans by expensing the estimated fair value of share-based awards over the requisite employee service period, which is the vesting period. The Company amortizes the fair value of equity awards granted on a straight-line basis over the requisite service periods of the awards. The measurement of share-based compensation expense is based on several criteria including, but not limited to, the valuation model used and associated input factors such as expected term of the award, stock price volatility, dividend rate, risk free interest rate, and award forfeiture rate. The input factors to use in the valuation model are based on subjective future expectations combined with management judgment. The Company uses historical data to estimate pre-vesting equity award forfeitures and records share-based compensation expense only for those awards that are expected to vest. The excess tax benefits recognized in equity related to equity award exercises are reflected as cash inflows from financing activities in the consolidated statements of cash flows.
Net Income (loss) per Common Share	'
	Securities that are entitled to participate in dividends with common stock, such as the Company’s Series A Conditional Convertible Preferred Stock (the “Preferred Stock”), are considered to be participating securities and the two-class method is used for purposes of calculating basic net income per share. Under the two-class method, a portion of net income is allocated to participating securities and excluded from the calculation of basic net income per common share. On December 21, 2012, all outstanding Preferred Stock were converted into common stock; accordingly, for the two-class method calculation, the net income was allocated between common stock and Preferred Stock on a proportionate basis using a systematic and reasonable basis (based on number of days outstanding) for purpose of calculating the basic net income per share for the year ended December 31, 2012. For the 2011 basic net loss per common share calculation, the two-class method was not applicable due to the overall net loss for the year. Diluted net income per common share reflects the effects of potentially dilutive share-based equity instruments and common stock issuable upon conversion of the Preferred Stock.
Discontinued Operations	'
	The results of operations of a disposal group held for sale or disposed is presented as discontinued operations when the underlying operations and cash flows of the disposal group will be, or have been, eliminated from the Company’s continuing operations and the Company no longer has the ability to influence the operating and/or financial policies of the disposal group. This assessment is made at the time the disposal group is classified as held for sale and for a one-year period after the sale of the disposal group.
Segment Information	'
	The Company’s management relies on internal management reporting processes that provide revenue and segment operating income for making financial decisions and allocating resources. Segment operating income includes income from operations before depreciation, amortization of intangible assets, share-based compensation expense and other unallocated corporate overhead. The Company’s management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.
Recently Adopted Accounting Pronouncements	'
	In July 2012, the Financial Accounting Standards Board issued an accounting standard update intended to simplify how an entity tests indefinite-lived intangible assets other than goodwill for impairment by providing entities with an option to perform a qualitative assessment to determine whether further impairment testing is necessary. This accounting standard update is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012. The Company adopted this guidance effective January 1, 2013 and performed a qualitative assessment on its annual impairment testing date and such adoption did not have a material effect on its consolidated financial statements. See Note (1)(h), “Summary of Significant Accounting Policies - Intangible Assets” for additional information.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Computation of basic and diluted net income (loss) per common share	'
	The following table sets forth the computation of basic and diluted net income (loss) per common share for the years ended December 31, 2013, 2012 and 2011, respectively:
		Years Ended December 31,
		2013		2012			2011
	Income from continuing operations	$	32,933	$	16,313		$	5,016
	Income (loss) from discontinued operations, net of tax	—		823			(31,281		)
	Net income (loss)	$	32,933	$	17,136		$	(26,265	)
	Less: Allocation to participating securities - from continuing operations	—		(1,249		)	—
	Allocation to participating securities - from discontinued operations	—		(65		)	—
	Total allocation to participating securities	—		(1,314		)	—
	Net income (loss) attributable to common stockholders - basic	$	32,933	$	15,822		$	(26,265	)
	Basic income (loss) per common share from:
	Continuing operations	$	0.72	$	0.36		$	0.12
	Discontinued operations	—		0.02			(0.78		)
	Net income (loss)	$	0.72	$	0.38		$	(0.66	)
	Diluted income (loss) per common share from:
	Continuing operations	$	0.69	$	0.35		$	0.11
	Discontinued operations	—		0.02			(0.68		)
	Net income (loss)	$	0.69	$	0.37		$	(0.57	)
	Weighted average common shares outstanding—basic	45,963		41,632			39,913
	Plus dilutive effect of potential common shares	1,824		5,077			6,038
	Weighted average common shares outstanding—diluted	47,787		46,709			45,951
Schedule of reconciliation of revenue and segment operating income by reportable segment to consolidated results	'
	The following table provides a reconciliation of revenue and segment operating income by reportable segment to consolidated results and was derived from the segment’s internal financial information as used for corporate management purposes:
		Years Ended December 31,
		2013		2012			2011
	Revenue
	Nurse and allied healthcare staffing	$	681,979	$	653,829		$	570,677
	Locum tenens staffing	287,484		261,431			277,919
	Physician permanent placement services	42,353		38,691			38,870
		$	1,011,816	$	953,951		$	887,466
	Segment Operating Income
	Nurse and allied healthcare staffing	$	82,458	$	75,907		$	62,786
	Locum tenens staffing	24,712		21,613			21,689
	Physician permanent placement services	8,929		7,868			10,634
		116,099		105,388			95,109
	Unallocated corporate overhead	30,927		31,674			34,040
	Depreciation and amortization	13,545		14,151			16,324
	Share-based compensation	6,125		6,221			7,098
	Interest expense, net (including loss on debt extinguishment of $434, $9,815, and $0 for the years ended December 31, 2013, 2012 and 2011, respectively)	9,665		26,019			23,727
	Income from continuing operations before income taxes	$	55,837	$	27,323		$	13,920

Discontinued_Operations_Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2013
Discontinued Operation, Income (Loss) from Discontinued Operation Disclosures [Abstract]	'
Components of discontinued operations, net of tax	'
	The following table represents the revenue and the components of discontinued operations, net of tax:
		2012			2011
	Revenue	$	3,885		$	53,954
	(Loss) before income taxes	$	(547	)	$	(38,484	)
	Income tax benefit	183			7,203
	Loss from discontinued operations	$	(364	)	$	(31,281	)
	Gain on sale of discontinued operations, before income taxes	$	3,825		$	—
	Income tax expense	(2,638		)	—
	Gain on sale of discontinued operations	$	1,187		$	—
	Total income (loss) from discontinued operations	$	823		$	(31,281	)

Fair_Value_Measurement_Tables

Fair Value Measurement (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'
	Financial assets measured at fair value on a recurring basis are summarized below:
		Fair Value Measurements as of December 31, 2013
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	17,817	$	17,817	$	—	$	—
	Money market funds	359		359		—		—
	Total financial assets measured at fair value	$	18,176	$	18,176	$	—	$	—
		Fair Value Measurements as of December 31, 2012
		Total		Quoted Prices in		Significant		Significant
				Active Markets		Other		Unobservable
				for Identical		Observable		Inputs
				Assets		Inputs		(Level 3)
				(Level 1)		(Level 2)
	U.S. Treasury securities	$	18,298	$	18,298	$	—	$	—
	Money market funds	42		42		—		—
	Total financial assets measured at fair value	$	18,340	$	18,340	$	—	$	—

Goodwill_and_Identifiable_Inta1

Goodwill and Identifiable Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Acquired Intangible Assets by Major Class	'
	As of December 31, 2013 and 2012, the Company had the following acquired intangible assets:
		As of December 31, 2013									As of December 31, 2012
		Gross			Accumulated			Net			Gross		Accumulated			Net
		Carrying			Amortization			Carrying			Carrying		Amortization			Carrying
		Amount						Amount			Amount					Amount
	Intangible assets subject to amortization:
	Staffing databases	$	5,450		$	(4,444	)	$	1,006		$	5,450	$	(3,839	)	$	1,611
	Customer relationships	72,990			(29,363		)	43,627			64,990		(24,539		)	40,451
	Tradenames and trademarks	16,871			(6,203		)	10,668			16,871		(5,231		)	11,640
	Non-compete agreements	1,666			(1,484		)	182			1,476		(1,468		)	8
	Acquired technology	6,200			(886		)	5,314			800		(800		)	—
	Online courses	59			(59		)	—			59		(59		)	—
		$	103,236		$	(42,439	)	$	60,797		$	89,646	$	(35,936	)	$	53,710
	Intangible assets not subject to amortization:
	Goodwill							$	144,642							$	123,324
	Tradenames and trademarks							89,400								83,200
								$	234,042							$	206,524
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	Based on the current amount of intangibles subject to amortization, the estimated amortization expense as of December 31, 2013 is as follows:
		Amount
	Year ending December 31, 2014	$	7,618
	Year ending December 31, 2015	7,414
	Year ending December 31, 2016	6,946
	Year ending December 31, 2017	6,729
	Year ending December 31, 2018	6,527
	Thereafter	25,563
		$	60,797
Schedule of Goodwill	'
	The following table summarizes the activity related to the carrying value of goodwill by reportable segment:
		Nurse and Allied		Locum Tenens			Physician		Home Healthcare Services		Total
		Healthcare Staffing		Staffing			Permanent
							Placement
							Services
	Balance, January 1, 2011	76,240		14,466			32,317		31,153		154,176
	Impairment charges	—		—			—		(24,498	)	(24,498	)
	Goodwill acquired from NFI acquisition	253		36			12		110		411
	Goodwill in assets held for sale	—		—			—		(6,765	)	(6,765	)
	Balance, December 31,2012	76,493		14,502			32,329		—		123,324
	Balance, January 1, 2013	76,493		14,502			32,329		—		123,324
	Goodwill acquired from ShiftWise acquisition	21,318		—			—		—		21,318
	Balance, December 31, 2013	97,811		14,502			32,329		—		144,642
	Accumulated impairment loss as of December 31, 2012 and 2013	154,444		53,940			6,555		—		214,939

Balance_Sheet_Details_Tables

Balance Sheet Details (Tables)	12 Months Ended
	Dec. 31, 2013
Balance Sheet Related Disclosures [Abstract]	'
Consolidated balance sheets detail	'
	The consolidated balance sheets detail is as follows as of December 31, 2013 and 2012:
		As of December 31,
		2013			2012
	Prepaids and other current assets:
	Prepaid expenses	$	8,128		$	7,282
	Restricted cash	8,325			2,540
	Income taxes receivable	3,084			337
	Other current assets	4,296			8,804
	Prepaids and other current assets	$	23,833		$	18,963
	Fixed assets:
	Furniture and equipment	$	16,413		$	15,786
	Software	62,471			60,195
	Leasehold improvements	5,305			5,062
		84,189			81,043
	Accumulated depreciation and amortization	(63,031		)	(66,228		)
	Fixed assets, net	$	21,158		$	14,815
	Accounts payable and accrued expenses:
	Trade and accrued accounts payable	$	29,857		$	26,229
	Accounts payable to agencies	7,431			—
	Subcontractor payable	22,051			18,129
	Professional liability reserve	8,485			6,535
	Other	1,583			1,726
	Accounts payable and accrued expenses	$	69,407		$	52,619
	Accrued compensation and benefits:
	Accrued payroll	$	17,216		$	14,992
	Accrued bonuses	11,359			10,812
	Accrued travel expense	2,203			3,132
	Accrued health insurance reserve	2,022			2,330
	Accrued workers compensation reserve	4,187			4,161
	Deferred compensation	17,731			13,935
	Other	107			81
	Accrued compensation and benefits	$	54,825		$	49,443
	Other current liabilities:
	Facility client deposits	$	2,409		$	2,831
	Bank overdraft	234			—
	Other	3,417			4,632
	Other current liabilities	$	6,060		$	7,463
	Other long-term liabilities:
	Workers compensation reserve	$	9,849		$	10,549
	Professional liability reserve	21,395			18,053
	Deferred rent	6,625			7,785
	Unrecognized tax benefits	27,178			24,593
	Deferred income taxes, net	17,764			5,281
	Other	2,717			1,311
	Other long-term liabilities	$	85,528		$	67,572

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of provision for income taxes from continuing operations	'
	The provision for income taxes from continuing operations for the years ended December 31, 2013, 2012 and 2011 consists of the following:
		Years Ended December 31,
		2013			2012			2011
	Current income taxes:
	Federal	$	17,268		$	3,334		$	8,493
	State	2,605			727			2,246
	Foreign	—			(2		)	(40		)
	Total	19,873			4,059			10,699
	Deferred income taxes:
	Federal	1,693			5,663			(1,500		)
	State	1,338			1,288			(390		)
	Foreign	—			—			95
	Total	3,031			6,951			(1,795		)
	Provision for income taxes from continuing operations	$	22,904		$	11,010		$	8,904
Schedule of income tax reconciliation	'
	The Company’s income tax expense differs from the amount that would have resulted from applying the federal statutory rate of 35% to pretax income (loss) from continuing operations because of the effect of the following items during the years ended December 31, 2013, 2012 and 2011:
		Years Ended December 31,
		2013			2012			2011
	Tax expense at federal statutory rate	$	19,543		$	9,563		$	4,871
	State taxes, net of federal benefit	2,302			1,263			1,067
	Unrecognized tax benefit	1,952			742			2,198
	Non-deductible goodwill and intangibles impairment	(19		)	(18		)	(18		)
	Other, net	(874		)	(540		)	786
	Income tax expense from continuing operations	$	22,904		$	11,010		$	8,904
Schedule of deferred tax assets and liabilities	'
	The tax effects of temporary differences that give rise to significant portions of deferred tax assets and deferred tax liabilities are presented below as of December 31, 2013 and 2012:
		Years Ended December 31,
		2013			2012
	Deferred tax assets:
	Stock compensation	$	11,998		$	11,100
	Deferred revenue	1,003			1,020
	Allowance for doubtful accounts	1,552			1,663
	Deferred compensation	7,116			5,246
	Accrued expenses, net	23,078			18,691
	Deferred rent	3,209			3,532
	Net operating losses	19,841			18,923
	State taxes	446			—
	Other	1,803			1,212
	Total deferred tax assets	$	70,046		$	61,387
	Deferred tax liabilities:
	Intangibles	$	(56,121	)	$	(43,782	)
	Fixed assets, net	(4,289		)	(3,484		)
	Prepaid expenses	(1,259		)	(813		)
	State taxes	—			(466		)
	Total deferred tax liabilities	$	(61,669	)	$	(48,545	)
	Valuation allowance	$	(1,205	)	$	—
	Net deferred tax assets	$	7,172		$	12,842
Schedule of unrecognized tax benefits	'
	A summary of the changes in the amount of unrecognized tax benefits for 2013, 2012 and 2011 is as follows:
		2013			2012			2011
	Beginning balance of unrecognized tax benefits	$	21,415		$	21,221		$	19,291
	Additions based on tax positions related to the current year	809			1,096			1,541
	Additions based on tax positions of prior years	349			—			512
	Reductions for tax positions of prior years	—			—			(123		)
	Reductions due to lapse of applicable statute of limitation	—			(902		)	—
	Ending balance of unrecognized tax benefits	$	22,573		$	21,415		$	21,221

Notes_Payable_and_Related_Cred1

Notes Payable and Related Credit Agreement (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of Credit Agreement Balances	'
	Credit Agreement balances as of December 31, 2013 and 2012 consisted of the following:
		As of December 31,
		2013			2012
	$50,000 Revolver Facility expiring April 5, 2017 with variable interest rates	$	10,000		$	—
	$200,000 Term Loan due April 5, 2018 with variable interest rates. The weighted average interest rates were 3.17% and 5.97% at December 31, 2013 and 2012, respectively	149,620			159,620
	Total credit agreement debt	159,620			159,620
	Less unamortized discount on the Term Loan	(948		)	(1,442		)
	Less current portion of notes payable, including Revolver	(10,000		)	—
	Long-term portion of notes payable	$	148,672		$	158,178
Schedule of annual principal maturities	'
	Annual principal maturities of outstanding debts, excluding the Revolver, are as follows:
	2014	$	—
	2015	—
	2016	—
	2017	—
	2018	149,620
		$	149,620

ShareBased_Compensation_Tables

Share-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of stock option and SAR activity	'
	A summary of stock option and SAR activity under the Stock Option Plan and the Equity Plan and Other Plans are as follows:
		Stock Option Plan							Equity Plan and Other Plans
		Number			Weighted-				Number			Weighted-
		Outstanding			Average				Outstanding			Average
					Exercise Price							Exercise Price
					per Share							per Share
	Outstanding at December 31, 2010	826			$	13.93			1,840			$	9.6
	Granted	—			$	—			—			$	—
	Exercised	—			$	—			(83	)		$	6.31
	Canceled/forfeited/expired	(45	)		$	11.54			(257	)		$	7.77
	Outstanding at December 31, 2011	781			$	14.06			1,500			$	10.1
	Granted	—			$	—			—			$	—
	Exercised	(55	)		$	9.68			(143	)		$	8.1
	Canceled/forfeited/expired	(28	)		$	15.63			(116	)		$	7.55
	Outstanding at December 31, 2012	698			$	14.34			1,241			$	10.57
	Granted	—			$	—			—			$	—
	Exercised	(109	)		$	11.23			(132	)		$	8.31
	Canceled/forfeited/expired	—			$	—			(13	)		$	15.19
	Outstanding at December 31, 2013	589			$	14.92			1,096			$	10.78
	Vested and expected to vest at December 31, 2013	589			$	14.92			1,096			$	10.78
	Exercisable at December 31, 2013	589			$	14.92			1,096			$	10.78
Schedule of stock options and SARs outstanding and exercisable	'
	The following table summarizes stock options and SARs outstanding and exercisable as of December 31, 2013:
				Outstanding									Exercisable
		Range		Number			Weighted-		Weighted-				Number	Weighted-	Weighted-
		Of		Outstanding			Average		Average				Outstanding	Average	Average
		Exercise					Remaining		Exercise Price					Remaining	Exercise Price
		Price					Contractual		per Share					Contractual	per Share
		per Share					Life (Years)							Life (Years)
	Stock Option Plan	$14.86		332			1.34		$	14.86			332	1.34	$	14.86
		$14.94 - $15.47		257			0.54		15				257	0.54	15
				589									589
	Equity Plan and Other Plans	$4.55 - $8.21		128			6.24		$	5.08			128	6.24	$	5.08
		$8.71 - $14.86		667			5.67		8.75				667	5.67	8.75
		$14.94 - $24.47		272			3.61		16.98				272	3.61	16.98
		$24.95		29			3.3		24.95				29	3.3	24.95
				1,096									1,096
	TOTAL			1,685			3.7		$	12.23			1,685	3.7	$	12.23
Schedule of RSU activity for non-vested awards	'
	The following table summarizes RSU and PRSU activity for non-vested awards for the years ended December 31, 2013, 2012 and 2011:
		Number of Shares			Weighted Average
					Grant Date
					Fair Value per
					Share
	Unvested at January 1, 2011	1,720			$	9.21
	Granted—RSUs	414			$	6.59
	Granted—PRSUs	288			$	8.53
	Vested	(725	)		$	10.77
	Canceled/forfeited/expired	(168	)		$	8.23
	Unvested at December 31, 2011	1,529			$	7.74
	Granted—RSUs	459			$	6.7
	Granted—PRSUs	465			$	8.15
	Vested	(716	)		$	7.95
	Canceled/forfeited/expired	(78	)		$	6.66
	Unvested at December 31, 2012	1,659			$	7.53
	Granted—RSUs	285			$	12.86
	Granted—PRSUs	291			$	13.86
	Vested	(588	)		$	7.02
	Canceled/forfeited/expired	(10	)		$	13.06
	Unvested at December 31, 2013	1,637			$	9.73
Schedule of share-based compensation expense	'
	The following table shows the total share-based compensation expense, related to all of the Company’s equity awards, recognized for the years ended December 31, 2013, 2012 and 2011:
		Years Ended December 31,
		2013				2012				2011
	Share-based employee compensation, before tax	$	6,125			$	6,224			$	7,132
	Related income tax benefits	(2,383		)		(2,403		)		(2,746		)
	Share-based employee compensation, net of tax	$	3,742			$	3,821			$	4,386

Commitments_and_Contingencies_1

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Lease Payments	'
	Future minimum lease payments under noncancelable operating leases (with initial or remaining lease terms in excess of one year) and future minimum capital lease payments as of December 31, 2013 are as follows:
		Capital		Operating
		Leases		Leases (1)
	Years ending December 31,
	2014	$	542	$	14,534
	2015	2		13,679
	2016	—		11,311
	2017	—		10,869
	2018	—		6,194
	Thereafter	—		—
	Total minimum lease payments	$	544	$	56,587
	Less amount representing interest (at rates ranging from 2.8% to 4.6%)	11
	Present value of minimum lease payments	533
	Less current installments of obligations under capital leases	533
	Obligations under capital leases, excluding current installments	$	—
	-1	Total future minimum lease payments have not been reduced by minimum sublease rents of $163 expected to be recovered under the operating subleases.

Quarterly_Financial_Data_Unaud1

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2013
Quarterly Financial Information Disclosure [Abstract]	'
Schedule of Quarterly Financial Information	'
		Year Ended December 31, 2013
		First		Second			Third		Fourth		Total Year
		Quarter		Quarter			Quarter		Quarter
		(In thousands, except per share data)
	Revenue	$	252,120	$	253,943		$	257,095	$	248,658	$	1,011,816
	Gross profit	$	73,007	$	74,413		$	75,667	$	74,193	$	297,280
	Net income	$	7,563	$	8,399		$	8,615	$	8,356	$	32,933
	Net income per share from:
	Basic	$	0.17	$	0.18		$	0.19	$	0.18	$	0.72
	Diluted	$	0.16	$	0.18		$	0.18	$	0.17	$	0.69
		Year Ended December 31, 2012
		First		Second			Third		Fourth		Total Year
		Quarter		Quarter			Quarter		Quarter
		(In thousands, except per share data)
	Revenue	$	226,412	$	235,786		$	243,912	$	247,841	$	953,951
	Gross profit	$	63,214	$	66,973		$	69,583	$	70,627	$	270,397
	Income from continuing operations, net of tax	$	3,453	$	(81	)	$	5,858	$	7,083	$	16,313
	Income (loss) from discontinued operations, net of tax	$	823	$	—		$	—	$	—	$	823
	Net income (loss)	$	4,276	$	(81	)	$	5,858	$	7,083	$	17,136
	Basic income (loss) per share from:
	Continuing operations	$	0.07	$	—		$	0.13	$	0.16	$	0.36
	Discontinued operations	$	0.02	$	—		$	—	$	—	$	0.02
	Net income (loss)	$	0.09	$	—		$	0.13	$	0.16	$	0.38
	Diluted income (loss) per share from:
	Continuing operations	$	0.07	$	—		$	0.12	$	0.15	$	0.35
	Discontinued operations	$	0.02	$	—		$	—	$	—	$	0.02
	Net income (loss)	$	0.09	$	—		$	0.12	$	0.15	$	0.37

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Restricted Cash, Cash Equivalents and Investments (Details)	12 Months Ended
	Dec. 31, 2013
Minimum	'
Restricted Cash and Cash Equivalents Items [Line Items]	'
U.S. Treasury Security Maturity Term	'6 months
Maximum	'
Restricted Cash and Cash Equivalents Items [Line Items]	'
U.S. Treasury Security Maturity Term	'12 months

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Fixed Assets (Details)	12 Months Ended
	Dec. 31, 2013
Furniture, Equipment and Software | Minimum	'
Property, Plant and Equipment [Line Items]	'
Fixed Assets, Useful Life	'3 years
Furniture, Equipment and Software | Maximum	'
Property, Plant and Equipment [Line Items]	'
Fixed Assets, Useful Life	'7 years
Software Development | Minimum	'
Property, Plant and Equipment [Line Items]	'
Fixed Assets, Useful Life	'3 years
Software Development | Maximum	'
Property, Plant and Equipment [Line Items]	'
Fixed Assets, Useful Life	'7 years

Summary_of_Significant_Account5

Summary of Significant Accounting Policies - Intangible Assets (Details) (USD $)	0 Months Ended			3 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Sep. 30, 2011
Indefinite-lived Intangible Assets [Line Items]	'	'	'	'
Impairment charges, indefinite-lived intangible assets	$0	$0	$7,700,000	$6,700,000

Summary_of_Significant_Account6

Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Concentration Risk [Line Items]	'	'
Restricted cash, cash equivalents and investments	23,115	18,861
Major Customers, Top Five Clients | Accounts Receivable | Customer Concentration Risk	'	'
Concentration Risk [Line Items]	'	'
Concentration risk percentage	12.00%	14.00%

Summary_of_Significant_Account7

Summary of Significant Accounting Policies - Net income per common share (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Computation of Basic and Diluted Net Income Per Common Share [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Income from continuing operations	$8,356	$8,615	$8,399	$7,563	$7,083	$5,858	($81)	$3,453	$32,933	$16,313	$5,016
Income (loss) from discontinued operations, net of tax	'	'	'	'	0	0	0	823	0	823	-31,281
Net income (loss)	'	'	'	'	7,083	5,858	-81	4,276	32,933	17,136	-26,265
Less: Allocation to participating securities - from continuing operations	'	'	'	'	'	'	'	'	0	-1,249	0
Allocation to participating securities - from discontinued operations	'	'	'	'	'	'	'	'	0	-65	0
Total allocation to participating securities	'	'	'	'	'	'	'	'	0	-1,314	0
Net income (loss) attributable to common stockholders - basic	'	'	'	'	'	'	'	'	$32,933	$15,822	($26,265)
Basic income (loss) per common share from:	'	'	'	'	'	'	'	'	'	'	'
Continuing operations (in dollars per share)	$0.18	$0.19	$0.18	$0.17	$0.16	$0.13	$0	$0.07	$0.72	$0.36	$0.12
Discontinued operations (in dollars per share)	'	'	'	'	$0	$0	$0	$0.02	$0	$0.02	($0.78)
Net income (loss) (in dollars per share)	'	'	'	'	$0.16	$0.13	$0	$0.09	$0.72	$0.38	($0.66)
Diluted income (loss) per common share from:	'	'	'	'	'	'	'	'	'	'	'
Continuing operations (in dollars per share)	$0.17	$0.18	$0.18	$0.16	$0.15	$0.12	$0	$0.07	$0.69	$0.35	$0.11
Discontinued operations (in dollars per share)	'	'	'	'	$0	$0	$0	$0.02	$0	$0.02	($0.68)
Net income (loss) (in dollars per share)	'	'	'	'	$0.15	$0.12	$0	$0.09	$0.69	$0.37	($0.57)
Weighted average common shares outstanding—basic	'	'	'	'	'	'	'	'	45,963	41,632	39,913
Plus dilutive effect of potential common shares	'	'	'	'	'	'	'	'	1,824	5,077	6,038
Weighted average common shares outstanding—diluted	'	'	'	'	'	'	'	'	47,787	46,709	45,951
Stock Compensation Plan	'	'	'	'	'	'	'	'	'	'	'
Class of Stock [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Common stock excluded from calculation of EPS	'	'	'	'	'	'	'	'	308	1,902	2,253

Summary_of_Significant_Account8

Summary of Significant Accounting Policies - Segment (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
									segment
Accounting Policies [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Reportable business segments	'	'	'	'	'	'	'	'	4	'	'
Segment Reporting Information, Profit (Loss) [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Revenue	$248,658	$257,095	$253,943	$252,120	$247,841	$243,912	$235,786	$226,412	$1,011,816	$953,951	$887,466
Operating Income	'	'	'	'	'	'	'	'	65,502	53,342	37,647
Depreciation and amortization	'	'	'	'	'	'	'	'	13,545	14,151	16,324
Share-based compensation	'	'	'	'	'	'	'	'	6,125	6,221	7,098
Interest expense, net (including loss on debt extinguishment of $434, $9,815, and $0 for the years ended December 31, 2013, 2012 and 2011, respectively)	'	'	'	'	'	'	'	'	9,665	26,019	23,727
Income from continuing operations before income taxes	'	'	'	'	'	'	'	'	55,837	27,323	13,920
Extinguishment of Debt, Gain (Loss), Net of Tax	'	'	'	'	'	'	'	'	434	9,815	0
Operating Segments	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information, Profit (Loss) [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	1,011,816	953,951	887,466
Operating Income	'	'	'	'	'	'	'	'	116,099	105,388	95,109
Operating Segments | Nurse and Allied Healthcare Staffing	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information, Profit (Loss) [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	681,979	653,829	570,677
Operating Income	'	'	'	'	'	'	'	'	82,458	75,907	62,786
Operating Segments | Locum Tenens Staffing	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information, Profit (Loss) [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	287,484	261,431	277,919
Operating Income	'	'	'	'	'	'	'	'	24,712	21,613	21,689
Operating Segments | Physician Permanent Placement Services	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information, Profit (Loss) [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	'	'	'	42,353	38,691	38,870
Operating Income	'	'	'	'	'	'	'	'	8,929	7,868	10,634
Corporate, Non-Segment	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information, Profit (Loss) [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Unallocated corporate overhead	'	'	'	'	'	'	'	'	$30,927	$31,674	$34,040

Summary_of_Significant_Account9

Summary of Significant Accounting Policies - Additional Textual (Details) (USD $)	0 Months Ended			12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Dec. 31, 2011
Accounting Policies [Abstract]	'	'	'	'
Impairment charges	$0	$0	$0	$24,498,000

Discontinued_Operations_Discon

Discontinued Operations Discontinued Operations (Details) (USD $)	0 Months Ended			3 Months Ended	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Sep. 30, 2011	Dec. 31, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'
Impairment charges	$0	$0	$0	'	$24,498,000
Impairment charges, indefinite-lived intangible assets	0	0	7,700,000	6,700,000	'
Income from discontinued operations	'	'	'	'	414,000
Trade Names	'	'	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'
Impairment charges, indefinite-lived intangible assets	'	'	'	'	$14,400,000

Discontinued_Operations_Revenu

Discontinued Operations - Revenues and Components of Discontinued Operations (Details) (USD $)	3 Months Ended				12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'	'	'
Gain on sale of discontinued operations	'	'	'	'	$0	$1,187	$0
Total income (loss) from discontinued operations	0	0	0	823	0	823	-31,281
Home Healthcare Services Segment	'	'	'	'	'	'	'
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]	'	'	'	'	'	'	'
Revenue	'	'	'	'	'	3,885	53,954
(Loss) before income taxes	'	'	'	'	'	-547	-38,484
Income tax benefit	'	'	'	'	'	183	7,203
Loss from discontinued operations	'	'	'	'	'	-364	-31,281
Gain on sale of discontinued operations, before income taxes	'	'	'	'	'	3,825	0
Income tax expense	'	'	'	'	'	-2,638	0
Gain on sale of discontinued operations	'	'	'	'	'	1,187	0
Total income (loss) from discontinued operations	'	'	'	'	'	$823	($31,281)

Business_Combinations_Details

Business Combinations (Details) (USD $)	12 Months Ended			0 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Nov. 20, 2013	Dec. 31, 2013
				Shiftwise Acquisition	Shiftwise Acquisition
Business Combination, Description	'	'	'	'	'
Total purchase price of the acquisition	'	'	'	$39,500	'
Amount deposited into escrow	'	'	'	6,000	'
Allocation of Purchase Price:	'	'	'	'	'
Fair value of assets acquired in acquisitions	9,899	0	0	'	9,899
Liabilities assumed	11,507	0	411	'	11,507
Deferred tax liability	'	'	'	'	2,639
Goodwill	21,318	0	411	'	21,318
Intangible assets	19,790	0	0	'	19,790
Intangible Assets, Net (Including Goodwill) [Abstract]	'	'	'	'	'
Weighted average useful life of intangible assets	'	'	'	'	'8 years
Acquisition-related costs	'	'	'	'	$389

Fair_Value_Measurement_Financi

Fair Value Measurement - Financial Assets and Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	$18,176	$18,340
US Treasury securities	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	17,817	18,298
Money market funds	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	359	42
Quoted Prices in Active Markets for Identical Assets (Level 1)	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	18,176	18,340
Quoted Prices in Active Markets for Identical Assets (Level 1) | US Treasury securities	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	17,817	18,298
Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	359	42
Significant Other Observable Inputs (Level 2)	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	0	0
Significant Other Observable Inputs (Level 2) | US Treasury securities	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	0	0
Significant Other Observable Inputs (Level 2) | Money market funds	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	0	0
Significant Unobservable Inputs (Level 3)	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	0	0
Significant Unobservable Inputs (Level 3) | US Treasury securities	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	0	0
Significant Unobservable Inputs (Level 3) | Money market funds	'	'
Schedule of financial assets and liabilities measured at fair value on recurring basis	'	'
Total financial assets measured at fair value	$0	$0

Fair_Value_Measurement_Nonfina

Fair Value Measurement - Non-financial Assets and Liabilities (Details) (USD $)	0 Months Ended			12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Dec. 31, 2011
Fair Value Disclosures [Abstract]	'	'	'	'
Goodwill, Total Losses	$0	$0	$0	$24,498,000

Goodwill_and_Identifiable_Inta2

Goodwill and Identifiable Intangible Assets - Acquired Intangible Assets (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010
In Thousands, unless otherwise specified
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Gross Carrying Amount	$103,236	$89,646	'
Accumulated Amortization	-42,439	-35,936	'
Net Carrying Amount	60,797	53,710	'
Goodwill	144,642	123,324	154,176
Intangible Assets, Net (Including Goodwill)	234,042	206,524	'
Trade Names and Trademarks	'	'	'
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Tradenames and trademarks	89,400	83,200	'
Staffing Databases	'	'	'
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Gross Carrying Amount	5,450	5,450	'
Accumulated Amortization	-4,444	-3,839	'
Net Carrying Amount	1,006	1,611	'
Customer Relationships	'	'	'
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Gross Carrying Amount	72,990	64,990	'
Accumulated Amortization	-29,363	-24,539	'
Net Carrying Amount	43,627	40,451	'
Trade Names and Trademarks	'	'	'
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Gross Carrying Amount	16,871	16,871	'
Accumulated Amortization	-6,203	-5,231	'
Net Carrying Amount	10,668	11,640	'
Non-compete Agreements	'	'	'
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Gross Carrying Amount	1,666	1,476	'
Accumulated Amortization	-1,484	-1,468	'
Net Carrying Amount	182	8	'
Acquired Technology	'	'	'
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Gross Carrying Amount	6,200	800	'
Accumulated Amortization	-886	-800	'
Net Carrying Amount	5,314	0	'
Online Courses	'	'	'
Schedule of Acquired Intangible Assets By Major Class [Line Items]	'	'	'
Gross Carrying Amount	59	59	'
Accumulated Amortization	-59	-59	'
Net Carrying Amount	$0	$0	'

Goodwill_and_Identifiable_Inta3

Goodwill and Identifiable Intangible Assets - Estimated Amortization Expense (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]	'	'
Aggregate amortization expense, intangible assets	$6,503	$6,665
Year ending December 31, 2014	7,618	'
Year ending December 31, 2015	7,414	'
Year ending December 31, 2016	6,946	'
Year ending December 31, 2017	6,729	'
Year ending December 31, 2018	6,527	'
Thereafter	25,563	'
Net Carrying Amount	$60,797	$53,710

Goodwill_and_Identifiable_Inta4

Goodwill and Identifiable Intangible Assets - Changes in the Carrying Amount of Goodwill (Details) (USD $)	0 Months Ended			12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Dec. 31, 2013	Dec. 31, 2011	Dec. 31, 2012
Goodwill [Roll Forward]	'	'	'	'	'	'
Beginning Balance	'	'	'	$123,324,000	$154,176,000	'
Impairment charges	0	0	0	'	-24,498,000	'
Goodwill acquired from acquisition	'	'	'	21,318,000	411,000	'
Goodwill, In Assets Held for Sale	'	'	'	'	-6,765,000	'
Ending Balance	'	'	'	144,642,000	'	'
Accumulated impariment loss	'	'	'	214,939,000	'	214,939,000
Nurse and Allied Healthcare Staffing	'	'	'	'	'	'
Goodwill [Roll Forward]	'	'	'	'	'	'
Beginning Balance	'	'	'	76,493,000	76,240,000	'
Impairment charges	'	'	'	'	0	'
Goodwill acquired from acquisition	'	'	'	21,318,000	253,000	'
Goodwill, In Assets Held for Sale	'	'	'	'	0	'
Ending Balance	'	'	'	97,811,000	'	'
Accumulated impariment loss	'	'	'	154,444,000	'	154,444,000
Locum Tenens Staffing	'	'	'	'	'	'
Goodwill [Roll Forward]	'	'	'	'	'	'
Beginning Balance	'	'	'	14,502,000	14,466,000	'
Impairment charges	'	'	'	'	0	'
Goodwill acquired from acquisition	'	'	'	0	36,000	'
Goodwill, In Assets Held for Sale	'	'	'	'	0	'
Ending Balance	'	'	'	14,502,000	'	'
Accumulated impariment loss	'	'	'	53,940,000	'	53,940,000
Physician Permanent Placement Services	'	'	'	'	'	'
Goodwill [Roll Forward]	'	'	'	'	'	'
Beginning Balance	'	'	'	32,329,000	32,317,000	'
Impairment charges	'	'	'	'	0	'
Goodwill acquired from acquisition	'	'	'	0	12,000	'
Goodwill, In Assets Held for Sale	'	'	'	'	0	'
Ending Balance	'	'	'	32,329,000	'	'
Accumulated impariment loss	'	'	'	6,555,000	'	6,555,000
Home Healthcare Services Segment	'	'	'	'	'	'
Goodwill [Roll Forward]	'	'	'	'	'	'
Beginning Balance	'	'	'	0	31,153,000	'
Impairment charges	'	'	'	'	-24,498,000	'
Goodwill acquired from acquisition	'	'	'	0	110,000	'
Goodwill, In Assets Held for Sale	'	'	'	'	-6,765,000	'
Ending Balance	'	'	'	0	'	'
Accumulated impariment loss	'	'	'	$0	'	$0

Balance_Sheet_Details_Details

Balance Sheet Details (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Prepaids and other current assets:	'	'
Prepaid expenses	$8,128	$7,282
Restricted cash	8,325	2,540
Income taxes receivable	3,084	337
Other current assets	4,296	8,804
Prepaids and other current assets	23,833	18,963
Fixed assets:	'	'
Furniture and equipment	16,413	15,786
Software	62,471	60,195
Leasehold improvements	5,305	5,062
Fixed Assets, Gross	84,189	81,043
Accumulated depreciation and amortization	-63,031	-66,228
Fixed assets, net	21,158	14,815
Accounts payable and accrued expenses:	'	'
Trade and accrued accounts payable	29,857	26,229
Accounts payable to agencies	7,431	0
Subcontractor payable	22,051	18,129
Professional liability reserve	8,485	6,535
Other	1,583	1,726
Accounts payable and accrued expenses	69,407	52,619
Accrued compensation and benefits:	'	'
Accrued payroll	17,216	14,992
Accrued bonuses	11,359	10,812
Accrued travel expense	2,203	3,132
Accrued health insurance reserve	2,022	2,330
Accrued workers compensation reserve	4,187	4,161
Deferred compensation	17,731	13,935
Other	107	81
Accrued compensation and benefits	54,825	49,443
Other current liabilities:	'	'
Facility client deposits	2,409	2,831
Bank overdraft	234	0
Other	3,417	4,632
Other current liabilities	6,060	7,463
Other long-term liabilities:	'	'
Workers compensation reserve	9,849	10,549
Professional liability reserve	21,395	18,053
Deferred rent	6,625	7,785
Unrecognized tax benefits	27,178	24,593
Deferred income taxes, net	17,764	5,281
Other	2,717	1,311
Other long-term liabilities	$85,528	$67,572

Income_Taxes_Provision_Details

Income Taxes - Provision (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Current income taxes:	'	'	'
Federal	$17,268	$3,334	$8,493
State	2,605	727	2,246
Foreign	0	-2	-40
Total	19,873	4,059	10,699
Deferred income taxes:	'	'	'
Federal	1,693	5,663	-1,500
State	1,338	1,288	-390
Foreign	0	0	95
Total	3,031	6,951	-1,795
Income tax expense from continuing operations	$22,904	$11,010	$8,904

Income_Taxes_Reconciliation_De

Income Taxes - Reconciliation (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Federal statutory tax rate	35.00%	35.00%	35.00%
Income tax reconciliation	'	'	'
Tax expense at federal statutory rate	$19,543	$9,563	$4,871
State taxes, net of federal benefit	2,302	1,263	1,067
Unrecognized tax benefit	1,952	742	2,198
Non-deductible goodwill and intangibles impairment	-19	-18	-18
Other, net	-874	-540	786
Income tax expense from continuing operations	$22,904	$11,010	$8,904

Income_Taxes_Deferred_Tax_Asse

Income Taxes - Deferred Tax Assets and Liabilities (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Deferred Tax Assets, Net [Abstract]	'	'
Stock compensation	$11,998	$11,100
Deferred revenue	1,003	1,020
Allowance for doubtful accounts	1,552	1,663
Deferred compensation	7,116	5,246
Accrued expenses, net	23,078	18,691
Deferred rent	3,209	3,532
Net operating losses	19,841	18,923
State taxes	446	0
Other	1,803	1,212
Total deferred tax assets	70,046	61,387
Deferred tax liabilities:	'	'
Intangibles	-56,121	-43,782
Fixed assets, net	-4,289	-3,484
Prepaid expenses	-1,259	-813
State taxes	0	-466
Total deferred tax liabilities	-61,669	-48,545
Valuation allowance	-1,205	0
Net deferred tax assets	7,172	12,842
Future taxable income required to fully realize deferred tax assets	$95,000	'

Income_Taxes_Operating_Loss_Ca

Income Taxes - Operating Loss Carryforwards (Details) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Federal	'
Operating Loss Carryforwards	'
Operating loss carryforwards	$45,308
State	'
Operating Loss Carryforwards	'
Operating loss carryforwards	50,000
Operating loss carryforward related to ShiftWise acquisition	$13,500

Income_Taxes_Unrecognized_Tax_

Income Taxes - Unrecognized Tax Benefits (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Tax Disclosure [Abstract]	'	'	'
Unrecognzied tax benefits that would affect the effective tax rate	$24,085	'	'
Temporary differences	3,093	'	'
Accrued interest and penalties related to uncertain tax positions	4,605	3,178	2,710
Interest and penalties recognized	1,427	468	709
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]	'	'	'
Beginning balance of unrecognized tax benefits	21,415	21,221	19,291
Additions based on tax positions related to the current year	809	1,096	1,541
Additions based on tax positions of prior years	349	0	512
Reductions for tax positions of prior years	0	0	-123
Reductions due to lapse of applicable statute of limitation	0	-902	0
Ending balance of unrecognized tax benefits	$22,573	$21,415	$21,221

Notes_Payable_and_Related_Cred2

Notes Payable and Related Credit Agreement (Details) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

0 Months Ended

Apr. 05, 2012

Dec. 31, 2013

Dec. 31, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 05, 2012

Apr. 09, 2013

Apr. 09, 2013

Apr. 09, 2013

Apr. 05, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 05, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 09, 2013

Apr. 05, 2012

Apr. 05, 2012

credit_facility

Revolving Credit Facility

Revolving Credit Facility

Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

Letter of Credit

Letter of Credit

London Interbank Offered Rate (LIBOR)

London Interbank Offered Rate (LIBOR)

London Interbank Offered Rate (LIBOR)

London Interbank Offered Rate (LIBOR)

London Interbank Offered Rate (LIBOR)

London Interbank Offered Rate (LIBOR)

London Interbank Offered Rate (LIBOR)

Base Rate

Base Rate

Base Rate

Base Rate

Base Rate

Base Rate

Base Rate

Maximum

Minimum

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

Term Loan

Term Loan

Term Loan

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

Term Loan

Term Loan

Term Loan

Maximum

Maximum

Minimum

Minimum

Maximum

Minimum

Maximum

Maximum

Minimum

Minimum

Maximum

Minimum

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of credit facilities

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Credit facility, available

'

$75,000,000

'

'

$50,000,000

'

$200,000,000

$200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net of unamortized original issue discount

'

'

'

'

'

'

2,000,000

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sublimit of issuance of letter of credit

'

'

'

'

20,000,000

'

'

'

'

'

30,000,000

20,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Sublimit for swingline loans

'

'

'

'

15,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum sublimit for revolver

'

37,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest rates spread over LIBOR and Base rate

'

'

'

'

'

'

'

'

'

'

'

'

2.75%

4.25%

2.25%

3.75%

3.00%

4.75%

4.50%

1.75%

3.25%

1.25%

2.75%

2.00%

3.75%

3.50%

Floor interest rates spread over borrowings under term loan

'

'

'

'

'

0.75%

1.25%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maturity date

'

'

'

'

5-Apr-17

'

'

5-Apr-18

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Remaining available borrowing capacity

'

30,485,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term portion of notes payable

'

148,672,000

158,178,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Term loan interest rate

'

3.75%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Voluntary prepayments on the new Term Loan

'

$10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reduction in interest rates

'

'

'

1.50%

'

0.50%

'

'

1.75%

1.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notes_Payable_and_Related_Cred3

Notes Payable and Related Credit Agreement - Components (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Apr. 05, 2012	Dec. 31, 2013	Dec. 31, 2012	Apr. 05, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
			Revolving Credit Facility	Revolving Credit Facility	Revolving Credit Facility	Term Loan	Term Loan	Term Loan	Standby Letters of Credit	Standby Letters of Credit	Secured Debt
				Line of Credit	Line of Credit		Line of Credit	Line of Credit
				Revolver Facility Expiring April 5, 2017	Revolver Facility Expiring April 5, 2017		Term Loan Due April 5, 2018	Term Loan Due April 5, 2018
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Total credit agreement debt	$159,620,000	$159,620,000	'	$10,000,000	$0	'	$149,620,000	$159,620,000	'	'	'
Less unamortized discount on the Term Loan	-948,000	-1,442,000	'	'	'	'	'	'	'	'	'
Less current portion of notes payable, including Revolver	-10,000,000	0	'	'	'	'	'	'	'	'	'
Long-term portion of notes payable	148,672,000	158,178,000	'	'	'	'	'	'	'	'	'
Credit facility, available	75,000,000	'	50,000,000	50,000,000	'	200,000,000	200,000,000	'	'	'	'
Maturity date	'	'	5-Apr-17	5-Apr-17	'	5-Apr-18	5-Apr-18	'	'	'	'
Weighted average interest rate	'	'	'	'	'	'	3.17%	5.97%	'	'	'
Letters of Credit	'	'	'	'	'	'	'	'	$27,691,000	$31,879,000	$18,176,000

Notes_Payable_and_Related_Cred4

Notes Payable and Related Credit Agreement - Maturities (Details) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Maturities of Long-term Debt [Abstract]	'
2014	$0
2015	0
2016	0
2017	0
2018	149,620
Total credit agreement debt	$149,620

Retirement_Plans_401k_Retireme

Retirement Plans - 401(k) Retirement Savings Plan (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Compensation and Retirement Disclosure [Abstract]	'	'	'
Employer contributions, net of foreitures	$165	$0	$0

Retirement_Plans_Deferred_Comp

Retirement Plans - Deferred Compensation Plan(Details) (Key Executives and Key Employees, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Key Executives and Key Employees	'	'	'	'
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]	'	'	'	'
Maximum Percent of Vested RSUs Deferrable	100.00%	'	'	'
Maximum Percent of Bonus Deferrable	90.00%	'	'	100.00%
Maximum Percent of Base Salary Deferrable	80.00%	'	'	'
Service vesting period	'5 years	'	'	'
Employer contributions	$384	$343	$327	'

Capital_Stock_Details

Capital Stock (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Jun. 30, 2013
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'	'	'	'
Preferred stock total shares including Series A	10,000	10,000	'	'
Preferred stock, par value	$0.01	$0.01	'	'
Preferred Stock, Shares Outstanding	0	0	'	'
Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]	'	'	'	'
Stock In Escrow For Indemnification Claims	'	457	'	'
Common Stock Released From Escrow	'	'	'	457
Treasury Stock, Shares	'	'	'	204
Holdback settlement in equity from prior acquisition	$3,046	$0	$0	'
Common Stock Returned To Former Acquired Company's Selling Shareholders	'	'	'	253

ShareBased_Compensation_Textua

Share-Based Compensation - Textual (Details) (USD $)

12 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

In Thousands, except Share data, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Mar. 05, 2012

Dec. 31, 2013

Dec. 31, 2013

Apr. 12, 2006

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Apr. 18, 2012

Apr. 09, 2009

Apr. 18, 2007

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2007

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Stock Appreciation Rights (SARs)

Stock Appreciation Rights (SARs)

Stock Appreciation Rights (SARs)

Stock Options and Stock Appreciation Rights

Stock Options and Stock Appreciation Rights

Stock Options and Stock Appreciation Rights

Restricted Stock Units (RSUs)

Restricted Stock Units (RSUs)

Performance Restricted Stock Units

Stock Option Plan

Stock Option Plan

Stock Option Plan

Stock Options

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Equity Plan

Stock Options

Stock Options

Stock Options and Stock Appreciation Rights

Stock Appreciation Rights (SARs)

Stock Options and Stock Appreciation Rights

Stock Options and Stock Appreciation Rights

Stock Options and Stock Appreciation Rights

Stock Options and Stock Appreciation Rights

Stock Options and Stock Appreciation Rights

Stock Options and Stock Appreciation Rights

Restricted Stock Units (RSUs)

Restricted Stock Units (RSUs)

Restricted Stock Units (RSUs)

Performance Restricted Stock Units

Performance Restricted Stock Units

Performance Restricted Stock Units

Vesting Period, Anniversary of Grant Date

Vesting Period, Annual

Vesting Period, Thirteen Month Aniversary of Grant Date

Vesting Period, Second Anniversary of Grant Date

vesting_period

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares authorized for issuance

'

'

'

'

'

'

'

'

'

'

4,178,000

'

'

'

'

'

'

'

'

723,000

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

'

'

'

'

'

'

'

'

'

'

'

25.00%

'

33.33%

'

'

'

'

'

'

'

33.00%

34.00%

'

'

'

Number of vesting periods

'

'

'

'

'

'

'

'

'

'

'

4

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares of common stock transferred between plans

'

'

'

'

'

'

'

'

'

371,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Contractual life of stock options and SARs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'10 years

'

'

'

'

'

'

'

'

Vesting period

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

'3 years

'

'

'

'

'

Additional number of shares authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,400,000

1,850,000

3,000,000

'

'

'

'

'

'

'

'

'

Shares of common stock reserved for future issuance

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

2,173,000

1,904,000

'

'

'

'

'

'

'

Granted shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

291,000

465,000

288,000

Restricted stock units, weighted average grant date intrinsic value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$13.86

$8.15

$8.53

Number outstanding, granted

0

0

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized compensation cost, weighted average remaining period

'

'

'

'

'

'

'

'1 year 9 months 18 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total intrinsic value of share-based payment award exercised

'

'

'

$980

$453

$183

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total intrinsic value of share-based payment award outstanding and exercisable

'

'

'

5,146

3,139

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Period for relative and absolute shareholder return

'

'

'

'

'

'

'

'

'3 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total unrecognized compensation cost

'

'

'

'

'

'

'

$6,631

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Aggregate instrinsic value

'

'

'

'

'

'

'

$24,070,000

$19,160,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

ShareBased_Compensation_Summar

Share-Based Compensation - Summary of Stock Option and SAR Activity (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Appreciation Rights (SARs)	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]	'	'	'
Number outstanding, granted	0	0	0
Stock Option Plan | Stock Options	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'	'	'
Number outstanding, Beginning balance	698	781	826
Number outstanding, granted	0	0	0
Number outstanding, exercised	-109	-55	0
Number outstanding, canceled/forfeited/expired	0	-28	-45
Number outstanding, Ending balance	589	698	781
Vested and expected to vest	589	'	'
Exercisable	589	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]	'	'	'
Weighted-average exercise price per share, Beginning balance	14.34	14.06	13.93
Weighted-average exercise price per share, granted	0	0	0
Weighted-average exercise price per share, exercised	11.23	9.68	0
Weighted-average exercise price per share, canceled/forfeited/expired	0	15.63	11.54
Weighted-average exercise price per share, Ending balance	14.92	14.34	14.06
Vested and expected to vest	14.92	'	'
Exercisable	14.92	'	'
Equity Plan and Other Plans | Stock Appreciation Rights (SARs)	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]	'	'	'
Number outstanding, Beginning balance	1,241	1,500	1,840
Number outstanding, granted	0	0	0
Number outstanding, exercised	-132	-143	-83
Number outstanding, canceled/forfeited/expired	-13	-116	-257
Number outstanding, Ending balance	1,096	1,241	1,500
Vested and expected to vest	1,096	'	'
Exercisable	1,096	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Roll Forward] [Roll Forward]	'	'	'
Weighted-average exercise price per share, Beginning balance	10.57	10.1	9.6
Weighted-average exercise price per share, granted	0	0	0
Weighted-average exercise price per share, exercised	8.31	8.1	6.31
Weighted-average exercise price per share, canceled/forfeited/expired	15.19	7.55	7.77
Weighted-average exercise price per share, Ending balance	10.78	10.57	10.1
Vested and expected to vest	10.78	'	'
Exercisable	10.78	'	'

ShareBased_Compensation_Stock_

Share-Based Compensation - Stock Options and SARs Outstanding and Exercisable (Details) (USD $)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	1,685,000
Weighted- Average Remaining Contractual Life (Years)	'3 years 8 months 12 days
Weighted- Average Exercise Price per Share	$12.23
Number Outstanding	1,685,000
Weighted- Average Remaining Contractual Life (Years)	'3 years 8 months 12 days
Weighted- Average Exercise Price per Share	$12.23
Stock Option Plan | Stock Options	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	589,000
Number Outstanding	589,000
Stock Option Plan | Stock Options | 14.86	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	332,000
Weighted- Average Remaining Contractual Life (Years)	'1 year 4 months 2 days
Weighted- Average Exercise Price per Share	$14.86
Number Outstanding	332,000
Weighted- Average Remaining Contractual Life (Years)	'1 year 4 months 2 days
Weighted- Average Exercise Price per Share	$14.86
Exercise Price Range, Upper Range Limit	$14.86
Stock Option Plan | Stock Options | 14.94 - $15.47	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	257,000
Weighted- Average Remaining Contractual Life (Years)	'6 months 14 days
Weighted- Average Exercise Price per Share	$15
Number Outstanding	257,000
Weighted- Average Remaining Contractual Life (Years)	'6 months 14 days
Weighted- Average Exercise Price per Share	$15
Exercise Price Range, Lower Range Limit	$14.94
Exercise Price Range, Upper Range Limit	$15.47
Equity Plan | Stock Appreciation Rights (SARs)	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	1,096,000
Number Outstanding	1,096,000
Equity Plan | Stock Appreciation Rights (SARs) | 4.55 - $8.21	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	128,000
Weighted- Average Remaining Contractual Life (Years)	'6 years 2 months 26 days
Weighted- Average Exercise Price per Share	$5.08
Number Outstanding	128,000
Weighted- Average Remaining Contractual Life (Years)	'6 years 2 months 26 days
Weighted- Average Exercise Price per Share	$5.08
Exercise Price Range, Lower Range Limit	4.55
Exercise Price Range, Upper Range Limit	8.21
Equity Plan | Stock Appreciation Rights (SARs) | 8.71 - $14.86	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	667,000
Weighted- Average Remaining Contractual Life (Years)	'5 years 8 months 1 day
Weighted- Average Exercise Price per Share	$8.75
Number Outstanding	667,000
Weighted- Average Remaining Contractual Life (Years)	'5 years 8 months 1 day
Weighted- Average Exercise Price per Share	$8.75
Exercise Price Range, Lower Range Limit	8.71
Exercise Price Range, Upper Range Limit	14.86
Equity Plan | Stock Appreciation Rights (SARs) | 14.94 - $24.47	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	272,000
Weighted- Average Remaining Contractual Life (Years)	'3 years 7 months 9 days
Weighted- Average Exercise Price per Share	$16.98
Number Outstanding	272,000
Weighted- Average Remaining Contractual Life (Years)	'3 years 7 months 9 days
Weighted- Average Exercise Price per Share	$16.98
Exercise Price Range, Lower Range Limit	14.94
Exercise Price Range, Upper Range Limit	24.47
Equity Plan | Stock Appreciation Rights (SARs) | 24.95	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding	29,000
Weighted- Average Remaining Contractual Life (Years)	'3 years 3 months 18 days
Weighted- Average Exercise Price per Share	$24.95
Number Outstanding	29,000
Weighted- Average Remaining Contractual Life (Years)	'3 years 3 months 18 days
Weighted- Average Exercise Price per Share	$24.95
Exercise Price Range, Upper Range Limit	24.95

ShareBased_Compensation_Restri

Share-Based Compensation - Restricted Stock Units (Details) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Performance Shares	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Period for Relative and Absolute Shareholder Return	'3 years	'	'
Equity Plan | Restricted Stock Units (RSUs)	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'	'
Unvested Shares, Beginning Balance	1,659	1,529	1,720
Vested shares	-588	-716	-725
Canceled/forfeited/expired shares	-10	-78	-168
Unvested Shares, Ending Balance	1,637	1,659	1,529
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]	'	'	'
Unvested weighted average fair value per share, Beginning Balance	$7.53	$7.74	$9.21
Vested weighted average fair value per share	$7.02	$7.95	$10.77
Canceled/forfeited/expired weighted average fair value per share	$13.06	$6.66	$8.23
Unvested weighted average fair value per share, Ending Balance	$9.73	$7.53	$7.74
Equity Plan | Nonperformance Shares	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'	'
Granted shares	285	459	414
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]	'	'	'
Granted weighted average fair value per share	$12.86	$6.70	$6.59
Equity Plan | Performance Shares	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]	'	'	'
Granted shares	291	465	288
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]	'	'	'
Granted weighted average fair value per share	$13.86	$8.15	$8.53
Minimum | Performance Shares	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percent of target amount granted to be issued	0.00%	'	'
Maximum | Performance Shares	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Percent of target amount granted to be issued	175.00%	'	'

ShareBased_Compensation_Share_

Share-Based Compensation - Share Based Compensation Expense (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'	'
Share-based employee compensation, before tax	$6,125	$6,224	$7,132
Related income tax benefits	-2,383	-2,403	-2,746
Share-based employee compensation, net of tax	$3,742	$3,821	$4,386

Commitments_and_Contingencies_2

Commitments and Contingencies (Details) (USD $)	0 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 05, 2008	Dec. 31, 2012	Mar. 28, 2012
Commitments and Contingencies Disclosure [Abstract]	'	'	'
Payment made to cease interest	$2,295	'	'
Amount Refunded on Settlement	'	'	2,012
Selling, general and administrative expenses	'	$2,012	'

Commitments_and_Contingencies_3

Commitments and Contingencies - Capital and Operating Leases (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012	Dec. 31, 2011
Capital and Operating Leases	'		'	'
Minimum sublease rents expected to be recovered under operating subleases	$163		'	'
Rent expense under operating leases for continuing operations	14,205		15,187	15,554
Capital Leases	'		'	'
2014	542		'	'
2015	2		'	'
2016	0		'	'
2017	0		'	'
2018	0		'	'
Thereafter	0		'	'
Total minimum lease payments	544		'	'
Less amount representing interest (at rates ranging from 2.8% to 4.6%)	11		'	'
Present value of minimum lease payments	533		'	'
Less current installments of obligations under capital leases	533		'	'
Obligations under capital leases, excluding current installments	0		'	'
Operating Leases	'		'	'
2014	14,534	[1]	'	'
2015	13,679	[1]	'	'
2016	11,311	[1]	'	'
2017	10,869	[1]	'	'
2018	6,194	[1]	'	'
Thereafter	0	[1]	'	'
Total minimum lease payments	$56,587	[1]	'	'
Minimum	'		'	'
Capital and Operating Leases	'		'	'
Interest rate of capital lease	2.80%		'	'
Maximum	'		'	'
Capital and Operating Leases	'		'	'
Interest rate of capital lease	4.60%		'	'
[1]	Total future minimum lease payments have not been reduced by minimum sublease rents of $163 expected to be recovered under the operating subleases.

Quarterly_Financial_Data_Unaud2

Quarterly Financial Data (Unaudited) (Details) (USD $)	0 Months Ended			3 Months Ended									12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Sep. 30, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Selected Quarterly Financial Information [Abstract]	'	'	'	'	'	'	'	'	'	'	'	'	'	'	'
Revenue	'	'	'	$248,658,000	$257,095,000	$253,943,000	$252,120,000	$247,841,000	$243,912,000	$235,786,000	$226,412,000	'	$1,011,816,000	$953,951,000	$887,466,000
Gross profit	'	'	'	74,193,000	75,667,000	74,413,000	73,007,000	70,627,000	69,583,000	66,973,000	63,214,000	'	297,280,000	270,397,000	249,319,000
Income from continuing operations	'	'	'	8,356,000	8,615,000	8,399,000	7,563,000	7,083,000	5,858,000	-81,000	3,453,000	'	32,933,000	16,313,000	5,016,000
Income (loss) from discontinued operations, net of tax	'	'	'	'	'	'	'	0	0	0	823,000	'	0	823,000	-31,281,000
Net income (loss)	'	'	'	'	'	'	'	7,083,000	5,858,000	-81,000	4,276,000	'	32,933,000	17,136,000	-26,265,000
Continuing operations (in dollars per share)	'	'	'	$0.18	$0.19	$0.18	$0.17	$0.16	$0.13	$0	$0.07	'	$0.72	$0.36	$0.12
Discontinued operations (in dollars per share)	'	'	'	'	'	'	'	$0	$0	$0	$0.02	'	$0	$0.02	($0.78)
Net income (loss) (in dollars per share)	'	'	'	'	'	'	'	$0.16	$0.13	$0	$0.09	'	$0.72	$0.38	($0.66)
Continuing operations (in dollars per share)	'	'	'	$0.17	$0.18	$0.18	$0.16	$0.15	$0.12	$0	$0.07	'	$0.69	$0.35	$0.11
Discontinued operations (in dollars per share)	'	'	'	'	'	'	'	$0	$0	$0	$0.02	'	$0	$0.02	($0.68)
Net income (loss) (in dollars per share)	'	'	'	'	'	'	'	$0.15	$0.12	$0	$0.09	'	$0.69	$0.37	($0.57)
Impairment charges	0	0	0	'	'	'	'	'	'	'	'	'	'	'	24,498,000
Impairment charges, indefinite-lived intangible assets	$0	$0	$7,700,000	'	'	'	'	'	'	'	'	$6,700,000	'	'	'

Schedule_II_Details

Schedule II (Details) (Allowance for Doubtful Accounts and Sales Returns, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
Allowance for Doubtful Accounts and Sales Returns	'		'		'
Movement in Valuation Allowances and Reserves [Roll Forward]	'		'		'
Balance at the Beginning of Year	$5,003		$4,761		$5,597
Expenses and Other Costs	1,901	[1]	2,353	[1]	2,776	[1]
Revenue Reductions	2,727	[2]	4,433	[2]	1,635	[2]
Deduction	-4,513	[3]	-6,544	[3]	-5,247	[3]
Balance at End of Year	$5,118		$5,003		$4,761
[1]	Includes increases in allowance for doubtful accounts.
[2]	Includes increases in sales allowance for potential credits issued to customers.
[3]	Includes actual write-offs of uncollectible accounts receivable and credits issued for sales adjustments.